10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________

FORM 10-Q

________________________

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2025

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ and ____________

Commission file number 001-41468

________________________

D-WAVE QUANTUM INC.

(Exact name of registrant as specified in its charter)

________________________

Delaware	88-1068854
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
2650 East Bayshore Road, Palo Alto, California	94303
(Address of Principal Executive Offices)	(Zip Code)

(604) 630-1428

Registrant's telephone number, including area code

________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.0001 per share	QBTS	New York Stock Exchange
Warrants, each whole warrant exercisable for 1.4541326 shares of common stock at an exercise price of $11.50	QBTS.WT	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No  ☐ 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒ 

APPLICABLE ONLY TO CORPORATE ISSUERS:

As of August 5, 2025, there were 338,605,149 outstanding shares of the registrant’s common stock, par value $0.0001 per share. In addition, there were 3,413,200 exchangeable shares outstanding as of August 5, 2025, which are convertible into shares of common stock on a one for one basis at any time for no consideration.

Table of Contents

		Page
Cautionary Note Regarding Forward-Looking Statements		2
Part I. Financial Information		3
Item 1.	D-Wave Quantum Inc. Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets (Unaudited)	3
	Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)	4
	Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited)	5
	Condensed Consolidated Statements of Cash Flows (Unaudited)	9
	Notes to Condensed Consolidated Financial Statements (Unaudited)	10
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	32
Item 4.	Controls and Procedures	33
Part II. Other Information		33
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	33
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34
Item 3.	Defaults Upon Senior Securities	34
Item 4.	Mine Safety Disclosures	34
Item 5.	Other Information	34
Item 6.	Exhibits	36
Signatures		37

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this Quarterly Report on Form 10-Q (this “Report”) may constitute “forward-looking statements” within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Our forward-looking statements include, but are not limited to, statements regarding D-Wave Quantum’s and D-Wave Quantum’s management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: “believe,” “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “trend,” “believe,” “estimate,” “predict,” “project,” “potential,” “seem,” “seek,” “future,” “outlook,” “forecast,” “projection,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Factors that might cause or contribute to a material difference include those risks discussed below and in Part I, Item 1A, “Risk Factors” in our most recent Annual Report on Form 10-K and our other filings with the Securities and Exchange Commission (the "SEC”). You should not place undue reliance on these forward-looking statements in making an investment decision with respect to our securities. These forward-looking statements are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability regarding future performance, events or circumstances. Many of the factors affecting actual performance, events and circumstances are beyond the control of D-Wave Quantum. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. All forward-looking statements set forth in this Report are qualified by these cautionary statements, and there can be no assurance that the actual results or developments anticipated by the Company will be realized or, even if substantially realized, that they will have the expected consequence to or effects on the Company or its business or operations. The following discussion should be read in conjunction with the Company’s audited Consolidated Financial Statements and related notes thereto included in our most recent Annual Report on Form 10-K. These forward-looking statements are based on information available as of the date of this Report, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties and are not predictions of actual performance. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

2

Part I - Financial Information

Item 1. Financial Statements

D-Wave Quantum Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

	June 30,		December 31,
(In thousands, except share and per share data)	2025		2024
Assets
Current assets:
Cash and cash equivalents	$	819,312	$	177,980
Trade accounts receivable, net of allowance for doubtful accounts of $1 and $176	1,442		1,420
Inventories	2,448		1,686
Prepaid expenses and other current assets	5,338		3,954
Total current assets	828,540		185,040
Property and equipment, net	4,504		4,133
Operating lease right-of-use assets	6,915		7,261
Intangible assets, net	586		490
Other non-current assets, net	3,057		2,929
Total assets	$	843,602	$	199,853
Liabilities and stockholders' equity
Current liabilities:
Trade accounts payable	$	1,190	$	815
Accrued expenses and other current liabilities	11,582		8,784
Current portion of operating lease liabilities	1,596		1,512
Loans payable, net, current	—		348
Deferred revenue, current	4,906		18,686
Total current liabilities	19,274		30,145
Warrant liabilities	91,037		69,875
Operating lease liabilities, net of current portion	6,322		6,389
Loans payable, net, non-current	32,061		30,128
Deferred revenue, non-current	654		670
Total liabilities	149,348		137,207
Commitments and contingencies (Note 9)
Stockholders' equity:
Common stock, par value $0.0001 per share; 675,000,000 shares authorized at both June 30, 2025 and December 31, 2024; 339,837,650 shares and 266,595,867 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively.	33		27
Additional paid-in capital	1,503,136		700,069
Accumulated deficit	(799,690)		(626,940)
Accumulated other comprehensive loss	(9,225)		(10,510)
Total stockholders' equity	694,254		62,646
Total liabilities and stockholders’ equity	$	843,602	$	199,853

    

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

D-Wave Quantum Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands, except share and per share data)	2025		2024		2025		2024
Revenue	$	3,095	$	2,183	$	18,096	$	4,648
Cost of revenue	1,119		795		2,243		1,601
Total gross profit	1,976		1,388		15,853		3,047
Operating expenses:
Research and development	12,694		8,355		22,982		16,880
General and administrative	9,151		7,471		17,108		15,037
Sales and marketing	6,633		4,401		13,556		7,485
Total operating expenses	28,478		20,227		53,646		39,402
Loss from operations	(26,502)		(18,839)		(37,793)		(36,355)
Other income (expense), net:
Interest expense	(206)		(1,160)		(432)		(2,300)
Change in fair value of Term Loan	—		(275)		—		924
Gain (loss) on investment in marketable securities	—		(157)		—		1,503
Change in fair value of warrant liabilities	(142,048)		2,195		(138,105)		(457)
Other income (expense), net	1,427		458		3,580		1,595
Total other income (expense), net	(140,827)		1,061		(134,957)		1,265
Net loss	$	(167,329)	$	(17,778)	$	(172,750)	$	(35,090)
Net loss per share, basic and diluted	$	(0.55)	$	(0.10)	$	(0.59)	$	(0.21)
Weighted-average shares used in computing net loss per share, basic and diluted	302,288,793		172,139,085		294,398,419		166,723,787
Comprehensive loss:
Net loss	$	(167,329)	$	(17,778)	$	(172,750)	$	(35,090)
Foreign currency translation adjustment	787		22		1,285		69
Net comprehensive loss	$	(166,542)	$	(17,756)	$	(171,465)	$	(35,021)

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

D-Wave Quantum Inc.

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

For the Three Months Ended June 30, 2025

(Unaudited)

	Common stock			Additional paid-in capital		Accumulated deficit		Accumulated other comprehensive loss		Total stockholders' equity
(In thousands, except share data)	Shares	Amount
Balance at March 31, 2025	291,351,403	$	29	$	849,733	$	(632,361)	$	(10,012)	$	207,389
Issuance of common stock in connection with the Lincoln Park Purchase Agreement	3,873,113	—		37,787		—		—		37,787
Issuance of common stock in at-the-market offerings, net of issuance costs	26,344,831	3		390,630		—		—		390,633
Issuance of common stock in connection with the Employee Stock Purchase Plan	95,331	—		291		—		—		291
Issuance of common stock in connection with exercise of stock options and vesting of RSUs	5,614,895	—		6,837		—		—		6,837
Issuance of common stock in connection with exercise of warrants	12,558,077	1		216,255		—		—		216,256
Stock-based compensation	—	—		6,750		—		—		6,750
Tax withholding related to vesting of restricted stock units	—	—		(5,147)		—		—		(5,147)
Foreign currency translation adjustment, net of tax	—	—		—		—		787		787
Net loss	—	—		—		(167,329)		—		(167,329)
Balances at June 30, 2025	339,837,650	$	33	$	1,503,136	$	(799,690)	$	(9,225)	$	694,254

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

D-Wave Quantum Inc.

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

For the Three Months Ended June 30, 2024

(Unaudited)

	Common stock			Additional paid-in capital		Accumulated deficit		Accumulated other comprehensive loss		Total stockholders' deficit
(In thousands, except share data)	Shares	Amount
Balances at March 31, 2024	161,675,010	$	16	$	473,870	$	(500,373)	$	(10,470)	$	(36,957)
Issuance of common stock in connection with the Lincoln Park Purchase Agreement	14,948,550	1		20,287		—		—		20,288
Issuance of common stock in at-the-market offerings, net of issuance costs	8,279,098	1		9,100		—		—		9,101
Issuance of common stock in connection with the Employee Stock Purchase Plan	262,777	—		171		—		—		171
Issuance of common stock under stock-based compensation plans	907,652	—		35		—		—		35
Stock-based compensation	—	—		4,221		—		—		4,221
Tax withholding related to vesting of restricted stock units	—	—		(617)		—		—		(617)
Foreign currency translation adjustment, net of tax	—	—		—		—		22		22
Net loss	—	—		—		(17,778)		—		(17,778)
Balances at June 30, 2024	186,073,087	$	18	$	507,067	$	(518,151)	$	(10,448)	$	(21,514)

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

D-Wave Quantum Inc.

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

For the Six Months Ended June 30, 2025

(Unaudited)

	Common stock			Additional paid-in capital		Accumulated deficit		Accumulated other comprehensive loss		Total stockholders' equity
(In thousands, except share data)	Shares	Amount
Balances at December 31, 2024	266,595,867	$	27	$	700,069	$	(626,940)	$	(10,510)	$	62,646
Issuance of common stock in connection with the Lincoln Park Purchase Agreement	3,873,113	—		37,787		—		—		37,787
Issuance of common stock in at-the-market offerings, net of issuance costs	50,948,852	5		536,736		—		—		536,741
Issuance of common stock in connection with the Employee Stock Purchase Plan	95,331	—		291		—		—		291
Issuance of common stock in connection with exercise of stock options and vesting of RSUs	5,766,016	—		6,860		—		—		6,860
Issuance of common stock in connection with exercise of warrants	12,558,471	1		216,261						216,262
Stock-based compensation	—	—		10,796		—		—		10,796
Tax withholding related to vesting of restricted stock units	—	—		(5,664)		—		—		(5,664)
Foreign currency translation adjustment, net of tax	—	—		—		—		1,285		1,285
Net loss	—	—		—		(172,750)		—		(172,750)
Balances at June 30, 2025	339,837,650	$	33	$	1,503,136	$	(799,690)	$	(9,225)	$	694,254

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

D-Wave Quantum Inc.

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

For the Six Months Ended June 30, 2024

(Unaudited)

	Common stock			Additional paid-in capital		Accumulated deficit		Accumulated other comprehensive loss		Total stockholders' deficit
(In thousands, except share data)	Shares	Amount
Balances at December 31, 2023	161,113,744	$	16	$	469,081	$	(483,061)	$	(10,517)	$	(24,481)
Issuance of common stock in connection with the Lincoln Park Purchase Agreement	14,948,550	1		20,287		—		—		20,288
Issuance of common stock in at-the-market offerings, net of issuance costs	8,279,098	1		9,100		—		—		9,101
Issuance of common stock in connection with the Employee Stock Purchase Plan	262,777	—		171		—		—		171
Issuance of common stock under stock-based compensation plans	1,468,918	—		43		—		—		43
Stock-based compensation	—	—		9,736		—		—		9,736
Tax withholding related to vesting of restricted stock units	—	—		(1,351)		—		—		(1,351)
Foreign currency translation adjustment, net of tax	—	—		—		—		69		69
Net loss	—	—		—		(35,090)		—		(35,090)
Balances at June 30, 2024	186,073,087	$	18	$	507,067	$	(518,151)	$	(10,448)	$	(21,514)

The accompanying notes are an integral part of these condensed consolidated financial statements.

8

D-Wave Quantum Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Six Months Ended June 30,
(in thousands)	2025		2024
Cash flows from operating activities:
Net loss	$	(172,750)	$	(35,090)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	714		510
Stock-based compensation	10,664		7,730
Amortization of operating right-of-use assets	346		398
Non-cash interest expense	387		2,211
Change in fair value of Warrant liabilities	138,105		457
Change in fair value of Term Loan	—		(924)
Gain on marketable securities	—		(1,503)
Unrealized foreign exchange loss (gain)	1,998		(1,274)
Other noncash items	267		—
Change in operating assets and liabilities:
Trade accounts receivable	(57)		9
Inventories	(762)		(147)
Prepaid expenses and other current assets	(1,368)		(339)
Trade accounts payable	416		(502)
Accrued expenses and other current liabilities	2,695		1,741
Deferred revenue	(13,796)		(125)
Operating lease liability	(344)		364
Other non-current assets, net	(1,080)		(103)
Net cash used in operating activities	(34,565)		(26,587)
Cash flows from investing activities:
Purchase of property and equipment	(1,187)		(850)
Purchase of convertible note (Note 4)	—		(1,000)
Proceeds from recovery of previously written-off note receivable (Note 4)	959		—
Sales of marketable securities (Note 4)	—		254
Expenditures for internal-use software	(129)		(213)
Net cash used in investing activities	(357)		(1,809)
Cash flows from financing activities:
Proceeds from the issuance of common stock pursuant to the Lincoln Park Purchase Agreement	37,787		20,288
Proceeds from the issuance of common stock in at-the-market offerings, net of issuance costs	536,741		9,100
Proceeds from issuance of common stock upon exercise of warrants	99,319		—
Proceeds from the issuance of common stock upon exercise of stock options	6,860		43
Proceeds from common stock issued under the Employee Stock Purchase Plan	291		171
Payment of tax withheld pursuant to stock-based compensation settlements	(5,664)		(1,351)
Repayments on TPC loan	(365)		(370)
Net cash provided by financing activities	674,969		27,881
Effect of exchange rate changes on cash and cash equivalents	1,285		69
Net increase (decrease) in cash and cash equivalents	641,332		(446)
Cash and cash equivalents at beginning of period	177,980		41,307
Cash and cash equivalents at end of period	$	819,312	$	40,861
Supplemental disclosure of non-cash investing and financing activities:
Capitalized stock-based compensation	$	132	$	—
Reclassification of warrant liability to equity upon exercise	$	116,943	$	—
Operating lease right-of-use assets exchanged for new operating lease obligations	$	—	$	476
Purchases of property and equipment included in accounts payable	$	—	$	239
Bonus settled in vested share based compensation awards	$	—	$	2,006

The accompanying notes are an integral part of these condensed consolidated financial statements.

9

D-Wave Quantum Inc.

Notes to Condensed Consolidated Financial Statements

1. DESCRIPTION OF BUSINESS

D-Wave Quantum Inc. ("D-Wave" or the “Company”) was incorporated as a corporation organized and existing under the General Corporation Law of the State of Delaware on January 24, 2022. The Company was formed for the purpose of effecting a merger between DPCM Capital, Inc. (“DPCM”), D-Wave Systems Inc. (“D-Wave Systems”), and certain other affiliated entities through a series of transactions (the “Merger”) pursuant to the definitive agreement entered into on February 7, 2022 (the “Transaction Agreement”). On August 5, 2022, in conjunction with the Merger, DPCM and D-Wave Systems became wholly-owned subsidiaries of, and are operated by, the Company. Upon the completion of the Merger, the Company succeeded to all of the operations of its predecessor, D-Wave Systems.

D-Wave is a commercial quantum computing company that provides customers with a full suite of professional services and web-based access to its superconducting quantum computer systems and integrated software environment through the LeapTM quantum cloud service. The Company also sells its superconducting quantum computer systems to customers. Historically, the Company has developed its own annealing superconducting quantum computer and associated software, with its current sixth-generation quantum computing system being the Advantage2TM.

D-Wave has three operating facilities, which it leases, in North America. These facilities are located in Burnaby, British Columbia, Richmond, British Columbia, and Palo Alto, California.

2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The unaudited interim condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosure normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the United States Securities and Exchange Commission ("SEC"). In the opinion of the Company, the unaudited financial information for the interim periods presented reflects all adjustments, which are normal and recurring, necessary for a fair presentation of the condensed consolidated balance sheets, condensed consolidated statements of operations and comprehensive loss, and condensed consolidated statements of cash flows. Interim results should not be regarded as indicative of results that may be expected for any other period or the entire year.

The interim condensed consolidated financial statements included herein have been prepared on the same basis as the audited annual consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K as of and for the year ended December 31, 2024 filed with the SEC on March 14, 2025.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in the condensed consolidated financial statements upon consolidation.

10

Use of estimates

The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. The most significant estimates and assumptions are used in determining: (i) inputs used to recognize revenue over time relating to hours estimated to complete the remaining performance obligations, (ii) fair value of financial instruments, and (iii) long term revenue forecasts used in the accounting for the SIF Loan (see below and Note 6 for further information). These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.

The Company’s accounting estimates and assumptions may change over time in response to risks and uncertainties, including uncertainty in the current economic environment due to inflation, tariffs, changes in interest rates and monetary policy, various geopolitical conflicts, and any evolutions thereof. The change could be material in future periods. As of the date of issuance of these condensed consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.

Investment in securities

The Company holds investments in the equity securities of privately held companies, which are valued based on their original cost. Adjustments are made for observable price changes in orderly transactions involving identical or similar securities of the same issuer, as there are no quoted market prices available.

The Company also held an investment in a convertible note (the "Note") of Zapata Computing, Inc. ("Zapata"). The Company accounted for the Note as a loan receivable pursuant to ASC 310, as the Note did not meet the definition of a security. On April 1, 2024, Zapata stock began trading on the Nasdaq Stock Market and as such became readily convertible to cash. The Company then bifurcated the conversion feature at fair value.

On October 11, 2024, Zapata announced that it was insolvent and would cease operations. Considering this and other financial information available prior to the balance sheet date as of December 31, 2024, the Note was provisionally determined to be uncollectible, and the Company has recognized a credit loss provision for the entire balance owed of $1.0 million as of December 31, 2024. The charge was recorded within general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss.

The Company was one of two senior-most secured creditors to Zapata. The Note was secured by substantially all of Zapata's assets, including cash accounts, accounts receivables, inventory, contract rights and general intangibles, intellectual property, and equipment, as set forth in the security agreements pertaining to the Note.

Subsequent to the write-off of the Note, in June 2025, the Company recovered the full principal balance of the Note, along with $0.2 million in interest and $0.1 million in legal fees. The recovery was recorded within general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss, offsetting the previously recorded credit loss provision and legal expenses. The cash received for the principal balance of the Note is presented within investing activities in the statement of cash flows. The interest was recorded within interest income (expense) in the condensed consolidated statements of operations and comprehensive loss.

Sales of future revenues

On November 20, 2020, the Company entered into an agreement with the Canada Strategic Innovation Fund ("SIF"), wherein SIF committed to providing a conditionally repayable loan to the Company in the amount of up to C$40.0 million (the "SIF Loan"). The SIF Loan is conditionally repayable according to a revenue-based formula. See Note 6 - Loans payable, net for additional information concerning the SIF Loan.

The accounting treatment for the SIF Loan considers the "sale of future revenues" guidance promulgated by ASC 470-10-25. The debt arising from the SIF Loan was recorded at face value and will be amortized using the effective interest method, leading to the accrual of interest expenses over the estimated term of the SIF Loan. The amortization schedule is based on projected cash flows derived from the Company's long-term revenue forecast. Subsequent changes in forecasted cash flows will be accounted for under the catch-up method, which entails adjusting the accrued interest portion of the principal balance through earnings to reflect the currently projected effective interest rate. The liability is classified as non-current, as the current forecast indicates that repayments will not commence within the 12 months following the balance sheet date.

11

As the SIF Loan is originated through a government program, a market rate of interest is not imputed in accordance with the scope limitation provisions of ASC 835.

Fair value of financial instruments

Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:

•Level 1—Quoted prices in active markets for identical assets or liabilities.

•Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.

•Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.

The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company recognizes transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. The Company did not transfer any assets or liabilities in or out of Level 3 during the six months ended June 30, 2025 or 2024.

The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis as of June 30, 2025 and indicates the place in the fair value hierarchy of the valuation inputs the Company utilized to determine each such fair value (in thousands):

Description	Level	As of June 30, 2025
Liabilities:
Warrant Liabilities – Public Warrants	1	$	36,343
Warrant Liabilities – Private Placement Warrants	2	$	54,694

The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss.

For periods subsequent to the detachment of the Public Warrants (as defined below) from the units, the close price of the Public Warrants was used as the fair value of the Warrants as of each relevant date. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units are classified as Level 1 fair value measurements due to the use of an observable market quote in an active market. The subsequent measurements of the Private Warrants after the detachment of the Public Warrants from the Units are classified as Level 2 fair value measurements due to the use of an observable market quote for the Public Warrants, which are considered to be a similar asset in an active market.

Recent accounting pronouncements issued and adopted

None.

Recent accounting pronouncements not yet adopted

Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which requires disaggregated information about our effective tax rate reconciliation as well as information on income taxes paid. The new guidance will first be effective in our annual disclosures for the year ending December 31, 2025, and should be applied on a prospective basis with the option to apply retrospectively. Early adoption is permitted. We are in the process of assessing the impact of ASU 2023-09 on our disclosures.

12

Expense Disaggregation Disclosures

In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

Climate Disclosures

In March 2024, the SEC adopted new climate disclosure rules requiring public companies to report on material climate-related risks, greenhouse gas emissions (Scopes 1 and 2), climate-related targets, and the financial impacts of severe weather events. However, following multiple legal challenges, the SEC stayed the implementation of these rules in April 2024 pending judicial review.

On March 27, 2025, the SEC announced it would cease defending these climate disclosure rules in court, effectively withdrawing its support for their enforcement.

On April 4, 2025, a group of 18 states and the District of Columbia moved to hold the cases in abeyance until the SEC amends or rescinds the regulations. The motion was granted by the U.S. Court of Appeals for the Eighth Circuit (the "Court") on April 24, 2025. Further, the Court directed the SEC to file a status report by July 23, 2025 to advise the Court whether the SEC intends to review or reconsider the rules at issue in the case. On July 23, 2025, the SEC requested that the Court lift the abeyance imposed on the litigation for the Court to issue a ruling.

While the rules technically remain in place, their future is uncertain as the litigation continues in the Court (Iowa v. SEC, No. 24-1522).

Despite the federal uncertainty, several U.S. states and international jurisdictions have enacted or proposed their own climate disclosure requirements. For instance, California's SB 253 and SB 261 mandate certain companies to disclose greenhouse gas emissions and climate-related financial risks. Additionally, the European Union's Corporate Sustainability Reporting Directive imposes extensive climate-related disclosure obligations on companies operating within its member states.

The Company is actively monitoring these developments and evaluating the potential impact of state and international climate disclosure requirements on its operations and reporting obligations.

3. REVENUE FROM CONTRACTS WITH CUSTOMERS

Disaggregation of revenue

Nature of Products and Services

The following table depicts the disaggregation of revenue by type of products or services and timing of transfer of products or services (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Type of products or services
System sales	$	1,025	$	—	$	13,672	$	—
QCaaS	1,241		1,779		2,774		3,471
Professional services	785		342		1,562		1,034
Other revenue*	44		62		88		143
Total revenue	$	3,095	$	2,183	$	18,096	$	4,648
Timing of revenue recognition
Revenue recognized over time	$	3,082	$	2,165	$	5,419	$	4,624
Revenue recognized at a point in time	13		18		12,677		24
Total revenue	$	3,095	$	2,183	$	18,096	$	4,648

*Other revenue includes support and maintenance and printed circuit board sales.

During the three months ended June 30, 2025, the Company recognized revenue of $1.0 million from a system upgrade project, which was classified under system sales.

13

Geographic Information

The following table presents a summary of revenue by geography for the three and six months ended June 30, 2025 and 2024, based on customer location (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Germany	$	1,186	$	492	$	13,990	$	1,005
United States	710		638		1,207		1,361
Japan	156		124		638		449
Canada	268		350		572		545
Switzerland	331		129		552		304
United Kingdom	62		69		227		197
Other	382		381		911		787
Total revenue	$	3,095	$	2,183	$	18,096	$	4,648

"Other" includes the rest of Europe, the Middle East, the rest of Asia and Australia where the revenue from a single country is not greater than 10% of total consolidated revenue. In accordance with Company policy, the Company has not had any sales in China, Russia or Ukraine.

Significant customers

A significant customer is defined as one that comprises up to ten percent or more of total revenues in a particular year or ten percent of outstanding accounts receivable balance as of the period end.

The tables below present the significant customers on a percentage of total revenue basis for the three and six months ended June 30, 2025 and 2024.

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Customer A	35	%	18	%	76	%	18	%
Customer B	11	%	—	%	—	%	—	%
Customer C	—	%	10	%	—	%	—	%

As of each of June 30, 2025 and 2024, there were five and one significant customers, respectively, that comprised ten percent or more of outstanding accounts receivable balances.

Contract balances

The following table provides information about accounts receivable, contract assets and liabilities as of June 30, 2025 and December 31, 2024 (in thousands):

	As of June 30, 2025		As of December 31, 2024
Trade accounts receivable and contract assets, net:
Trade accounts receivable, net of allowance for doubtful accounts and excluding unbilled receivables	$	820	$	867
Contract asset for unbilled receivables	622		553
Contract acquisition costs	287		174
Total contract assets	$	1,729	$	1,594
Contract liabilities:
Deferred revenue, current	$	4,906	$	18,686
Deferred revenue, non-current	654		670
Customer deposit1	—		48
Total contract liabilities	$	5,560	$	19,404

1Customer deposit is included in accrued expenses and other current liabilities on the condensed consolidated balance sheets.

14

The allowance for credit losses related to trade accounts receivable was immaterial and $0.2 million as of June 30, 2025 and December 31, 2024. During the three months and six months ended June 30, 2025, the Company recorded $0.1 million write-offs of accounts receivable deemed uncollectible, respectively. During the three months and six months ended June 30, 2024, the Company recorded minimal write-offs of accounts receivable deemed uncollectible.

The revenue recognized in the condensed consolidated statements of operations and comprehensive loss that was included in the contract liability balance at the beginning of each period was $14.6 million and $1.5 million for the six months ended June 30, 2025 and 2024, respectively.

Changes in deferred revenue from contracts with customers were as follows (in thousands):

	Six Months Ended June 30,
	2025		2024
Balance at beginning of period	$	19,356	$	2,748
Deferral of revenue	4,313		4,553
Recognition of deferred revenue	(18,109)		(4,678)
Balance at end of period	$	5,560	$	2,623

Remaining performance obligations

A significant number of the Company’s product and service sales are short-term in nature with a contract term of one year or less. For those contracts, the Company has utilized the practical expedient in ASC 606-10-50-14, exempting the Company from disclosure of the transaction price allocated to remaining performance obligations if the performance obligation is part of a contract that has an original expected duration of one year or less.

As of June 30, 2025, the aggregate amount of remaining performance obligations that were unsatisfied or partially unsatisfied related to customer contracts was $5.3 million, of which approximately 79% is expected to be recognized to revenue in the next 12 months, 91% is expected to be recognized to revenue in the next two years, and 96% is expected to be recognized within three years. Revenues allocated to remaining performance obligations represents the transaction price of noncancellable orders for which service has not been performed, which include deferred revenue and the amounts that will be invoiced and recognized as revenues in future periods from open contracts and excludes unexercised renewals.

4. BALANCE SHEET DETAILS

Inventories

Inventories consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Raw materials	$	2,446	$	1,677
Work-in-process	2		9
Total inventories	$	2,448	$	1,686

Prepaid expenses and other current assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Prepaid services	$	2,058	$	977
Interest receivable	995		—
Prepaid software	928		845
Prepaid insurance	458		382
Prepaid rent	108		156
Other	791		1,594
Total prepaid expenses and other current assets	$	5,338	$	3,954

15

Other non-current assets, net

Other non-current assets, net consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Investment in equity securities	$	2,574	$	2,574
Long-term deposits	196		181
Contract acquisition costs, net	287		174
Total	$	3,057	$	2,929

On January 5, 2024, an entity the Company had invested in was acquired by another entity and the transaction was determined to result in an observable price change in the equity security. Consequently, the carrying value of the Company's investment was adjusted based on the consideration received, resulting in a net gain of approximately $1.7 million, recorded in gain on investment in marketable securities on the condensed consolidated statements of operations and comprehensive loss during the six months ended June 30, 2024.

On February 8, 2024, the Company entered into a collaboration arrangement with Zapata to develop and bring to market commercial applications that combine generative AI and quantum computing technologies. As part of the collaboration, the Company purchased the Note with a principal amount of $1.0 million from Zapata. The Note matures on December 15, 2026, and bears interest at 15% per annum. The Note is prepayable without penalty after December 15, 2025 or if the aggregate value of Zapata's convertible notes outstanding falls below $3.0 million. The Note was convertible into Zapata common stock at the Company's option at a conversion price of $8.50, subject to adjustment for stock splits, recapitalizations, and other similar corporate transactions.

On April 1, 2024 the conversion feature associated with the Note was bifurcated from the debt host instrument in connection with the underlying stock becoming readily convertible to cash as the result of a de-SPAC transaction. As a result, the fair value of the conversion feature of $0.2 million was given separate recognition. During the six months ended June 30, 2024, the fair value of the conversion feature was immaterial, resulting in a loss of $0.2 million recorded to gain on investment in marketable securities on the condensed consolidated statements of operations and comprehensive loss.

On October 11, 2024, Zapata announced that it was insolvent and would cease operations. Considering this and other financial information available prior to the balance sheet date as of December 31, 2024, the Note was provisionally determined to be uncollectible, and the Company has recognized a credit loss provision for the entire balance owed of $1.0 million during the year ended December 31, 2024. The charge was recorded within general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss.

The Company was one of two senior-most secured creditors to Zapata. The Note was secured by substantially all of Zapata's assets, including cash accounts, accounts receivables, inventory, contract rights and general intangibles, intellectual property, and equipment, as set forth in the security agreements pertaining to the Note.

Subsequent to the write-off of the Note, in June 2025, the Company recovered the full principal balance of the Note, along with $0.2 million in interest and $0.1 million in legal fees. The recovery was recorded within general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss, offsetting the previously recorded credit loss provision and legal expenses. The cash received for the principal balance of the Note is presented within investing activities in the statement of cash flows. The interest was recorded within Other income, net in the condensed consolidated statements of operations and comprehensive loss.

See Note 2 - Basis of Presentation and Summary of Significant Accounting Policies for additional discussion.

Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Accrued compensation and related benefits	$	7,308	$	5,499
Accrued professional services	1,485		529
Other accruals	2,789		2,756
Total accrued expenses and other current liabilities	$	11,582	$	8,784

16

5. PROPERTY AND EQUIPMENT, NET

Property and equipment, net consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Quantum computer systems	$	13,781	$	14,471
Lab equipment	7,140		6,862
Computer equipment	4,918		4,701
Leasehold improvements	2,213		1,889
Furniture and fixtures	509		381
Construction-in-progress	1,064		836
Total property and equipment	29,625		29,140
Less: Accumulated depreciation	(25,121)		(25,007)
Total property and equipment, net	$	4,504	$	4,133

Depreciation expense for the three months ended June 30, 2025 and 2024 was $0.3 million and $0.2 million, respectively. Depreciation expense for the six months ended June 30, 2025 and 2024 was $0.6 million and $0.4 million, respectively.

6. LOANS PAYABLE, NET

As of June 30, 2025 and 2024, loans payable, net, consisted of the SIF Loan, the TPC loan (as defined below) and the Term Loan (as defined below). The following tables show the components of loans payable (in thousands):

	Effective Interest Rate	As of June 30, 2025		As of December 31, 2024
Loans payable, net, current:
TPC Loan, current	Interest free	$	—	$	348
Total loans payable, net, current		$	—	$	348
Loans payable, net, non-current:
SIF Loan	Variable1	$	32,061	$	30,128
Total loans payable, net, non-current		$	32,061	$	30,128

1Refer below for additional information on the SIF Loan repayment period and effective interest rate.

TPC loan

During the period spanning 2010 through 2021, the Company received funding totaling C$12.5 million from Technology Partnerships Canada (the "TPC Loan"). On November 23, 2020, an amendment forgave C$5.0 million of unpaid accrued debt principal and interest from prior years. Additionally, the amendment waived the interest charge on the remaining C$2.5 million of principal and revised the repayment schedule to C$0.5 million due annually on each April 30 through 2025. The TPC loan was fully repaid on April 24, 2025.

SIF Loan

On November 20, 2020, the Company entered into the SIF Loan. As of December 31, 2023, the Company had received the full C$40.0 million in eight tranches between November 2020 and December 2023. Funds from the SIF Loan were used for projects involving the adaptation of research findings for commercial applications that have the potential for market disruption; development of current product and services through the implementation of new or incremental technology that will enhance the Company’s competitive capability; and development of process improvements which reduce the environmental footprint of current production through the use of new or improved technologies.

Principal and interest amounts to be repaid under the SIF Loan are determined using a revenue-based formula, and are capped at 150% of the principal amount (the "Repayment Cap"). Repayments are due in up to 15 annual installments, commencing on April 30 of the second fiscal year following the fiscal year in which the Company first reports annual revenue of at least $70.0 million (the "Benchmark Year"). If the Company fails to reach $70.0 million in annual revenue after 14 years from origination, or if the total of the 15 revenue-based annual installments is less than the principal amount, any remaining repayment obligation will be forgiven.

17

Repayments of the SIF Loan can also be triggered upon default of the agreement, termination of the agreement, or upon a change of control that has not been approved by the Canadian government. As of June 30, 2025, the Company is not aware of any events that would trigger default or termination of the agreement.

The gross proceeds of the SIF Loan were recorded as a liability related to the sale of future revenues (see Note 2 - Basis of Presentation and Summary of Significant Accounting Policies). As of June 30, 2025 and December 31, 2024, the Company calculated a weighted average effective interest rate for all tranches of 2.46% based on the most recent revenue projections at each reporting date.

The estimated fair value of the SIF Loan (Level 3) at June 30, 2025 was $10.1 million. The fair value of SIF Loan was valued using a discounted cash flow model, with significant assumptions relating to the amount and timing of future revenues and the appropriate discount rate.

Term Loan

On April 13, 2023, the Company entered into the Term Loan with PSPIB Unitas Investments II Inc. ("PSPIB"), a related party to the Company's then largest shareholder. Under the Term Loan, term loans in aggregate principal amount of $50.0 million were to be made available to the Company in three tranches, subject to certain terms and conditions.

The Company fully repaid and extinguished the Term Loan on October 22, 2024, including $30.0 million in principal and $4.3 million in accrued payable in kind ("PIK") interest. The Term Loan, originally set to mature on March 31, 2027, was secured by a first-priority security interest in substantially all of the Company's assets and included certain operational and financial covenants. It bore interest at either 10.0% payable in cash or 11.0% PIK, with the latter added to the principal balance. For the three months ended June 30, 2025 and 2024, the Company recognized zero and $0.9 million, respectively, in interest expense. For the six months ended June 30, 2025 and 2024, the Company recognized zero and $1.8 million, respectively, in interest expense.

Throughout 2023 and 2024, multiple amendments were made to the Term Loan, including covenant waivers, modifications to prepayment requirements, and exemptions for certain share issuance proceeds. The sixth and final amendment, entered on April 16, 2024, provided temporary prepayment exemptions for up to $30.0 million in proceeds from share issuances, with an additional $20.0 million exempt from the 10% prepayment premium.

With the full repayment of the Term Loan, the Company has no remaining obligations under this facility.

18

7. WARRANT LIABILITIES

Public and Private Warrants

In conjunction with the Merger, the Company assumed 10,000,000 DPCM public warrants (the "Public Warrants") and 8,000,000 DPCM private warrants (the "Private Warrants"; collectively with the Public Warrants, the "Warrants").

During the six months ended June 30, 2025, 8,636,509 Warrants were exercised by holders in accordance with the Warrant Agreement (as defined below). As a result of these exercises, the Company issued 12,558,471 Common Shares. In connection with the exercises, the Company received cash proceeds of $99.3 million and reclassified $116.9 million, representing the fair value of the warrant liabilities at the time of exercise, from warrant liabilities to additional paid-in capital. The fair value of the liability pertaining to the exercised Warrants was remeasured immediately prior to exercise, and the change in fair value was recognized within change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss.

As of June 30, 2025, the Company has 9,280,047 Warrants outstanding. As part of the Merger, each DPCM Public Warrant and Private Warrant that was issued and outstanding immediately prior to the Merger was automatically and irrevocably converted into one warrant of the Company. The Warrants are subject to the terms and conditions of the warrant agreement entered into between DPCM and Continental Stock Transfer & Trust Company, as amended by an assignment, assumption and amendment agreement with the Company, and further amended to date (as so amended, the “Warrant Agreement”). Effective as of March 11, 2025, Equiniti Trust Company, LLC serves as the warrant agent under the Warrant Agreement.

Each such Warrant is exercisable at an exercise price of $11.50 for 1.4541326 Common Shares, or an approximate exercise price per Common Share of $7.91 (the "Per Share Exercise Price"), subject to adjustments. The Warrants may be exercised for a whole number of Common Shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants will expire on August 5, 2027, or earlier upon redemption or liquidation.

The Private Warrants are identical to the Public Warrants except that, so long as they are held by the initial purchasers or their permitted transferees, the Private Warrants are exercisable by the holders on a cashless basis and are non-redeemable by the Company except as described in the third bullet below. If the Private Warrants are held by holders other than the initial purchasers or their permitted transferees, the Private Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The Company may redeem the outstanding Public Warrants:

•in whole and not in part;

•at $0.01 per Warrant upon a minimum of 30 days' prior written notice of redemption; provided that the last reported sales price of the Common Shares for any twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on which such prior written notice is given (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalization and the like, the "Reference Value") equals or exceeds $18.00 per share;

•alternatively, at $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption; provided that the Reference Value equals or exceeds $10.00 per share, and if the Reference Value is less than $18.00 per share, the outstanding Private Warrants must also be concurrently called for redemption on the same terms as the Public Warrants; and provided further, that the holders may elect to exercise their Warrants on a "cashless basis" prior to redemption and receive a "make-whole exercise" number of Common Shares determined based on the redemption date relative to the remaining period to expiration of the Warrants and the fair market value per Common Share (as described in the Warrant Agreement); and

•if, and only if, there is an effective registration statement covering the issuance of the Common Shares issuable upon exercise of the Warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given, or an exemption from registration is available.

19

If the Company calls Warrants for redemption as described in either the second or third bullet above, the Company will have the option to require all holders of such Warrants to exercise the Warrants on a “cashless basis,” as described in the Warrant Agreement.

The exercise price and number of Common Shares issuable upon exercise of the Warrants may be adjusted in certain circumstances including in the event of a stock dividend, recapitalization, reorganization, merger or consolidation. However, the Warrants will not be adjusted for issuance of Common Shares at a price below the Per Share Exercise Price. Additionally, in no event will the Company be required to net cash settle the Warrants.

D-Wave Systems Warrant Transaction Agreements

In November 2020, contemporaneously with a revenue arrangement, D-Wave Systems entered into a contract pursuant to which D-Wave Systems agreed to cancel a previously issued warrant with a customer and replace it with a warrant to acquire up to 3,247,637 shares of its Class A Preferred Shares (the “Warrant Preferred Shares”), subject to certain vesting requirements. The warrant agreement was amended on August 5, 2022, contemporaneously with the closing of the Merger, to convert the Warrant Preferred Shares to a warrant to acquire up to 2,889,282 Common Shares of the Company in accordance with the conversion ratio of 0.889657 (the "Conversion Ratio") established in the Merger. The warrants vest based on various contractual milestones. The warrant agreement was terminated on November 28, 2022. As of the termination date of the agreement, approximately 40% of the warrants had vested, resulting in warrants exercisable into 1,155,713 Common Shares remaining after the termination date. The vested warrants will remain exercisable for up to 1,155,713 Common Shares at an exercise price of $2.16 per Common Share until November 29, 2026. As of June 30, 2025, no additional Warrant Preferred Shares were vested and/or were probable of vesting.

8. STOCK-BASED COMPENSATION

2020 Equity Incentive Plan

In April 2020, the Board of Directors of D-Wave Systems approved the 2020 Equity Incentive Plan (the "2020 Plan") which provides for the grant of qualified incentive stock options ("ISO") and non-qualified stock options ("NSO"), restricted stock, RSU or other awards to the Company’s employees, officers, directors, advisors, and outside consultants. Following the Merger, awards outstanding under the 2020 Plan continued to be governed by the 2020 Plan; however, the Company will not grant any further awards under the 2020 Plan.

2022 Equity Incentive Plan

On August 5, 2022, the shareholders approved the D-Wave Quantum Inc. 2022 Equity Incentive Plan (the “2022 Plan”), which became effective immediately upon the closing of the Merger. While the 2022 Plan allows for the issuance of awards with a service condition, a performance condition, a market condition, or some combination of the three, to date, the Company has only issued awards subject to a service condition. Awards issued under the 2022 Plan have vesting periods ranging from under 1 year to 4 years from the original grant date, and all awards issued to date under the 2022 Plan will expire 10 years from the original grant date.

Share-based compensation awards are settled by issuing new shares.

Common stock option activity

The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data):

	Number of options	Weighted  average  exercise price  ($)	Weighted average remaining contractual term (years)	Aggregate intrinsic value ($)
Outstanding as of December 31, 2024	10,984,738	1.67	6.64	75,270
Granted	—	—
Exercised	(4,202,187)	1.65
Forfeited and expired	(6,118)	4.73
Outstanding as of June 30, 2025	6,776,433	1.67	6.31	87,857
Options exercisable as of June 30, 2025	5,652,479	1.48	5.91	74,408
Options unvested as of June 30, 2025	1,123,954	2.67	8.33	13,449

During the six months ended June 30, 2025 and 2024, the total intrinsic value of options exercised was $63.5 million and immaterial, respectively.

20

Restricted stock unit awards

The following table summarizes the restricted stock unit ("RSU") activity and related information under the 2022 Plan:

	Number of RSUs	Weighted average Grant Date Fair Value ($)
Unvested as of December 31, 2024	8,787,022	2.25
Granted	4,773,987	9.28
Forfeited and expired	(166,418)	4.88
Vested	(2,499,947)	2.47
Unvested as of June 30, 2025	10,894,644	5.24

Employee Stock Purchase Plan

During the six months ended June 30, 2025, 95,331 Common Shares were issued under the Employee Stock Purchase Plan (the "ESPP"), and compensation cost recognized related to the ESPP was $0.2 million.

Stock-based compensation expense

The following table summarizes the stock-based compensation expense classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Cost of revenue	$	231	$	154	$	373	$	329
Research and development	2,329		1,311		3,783		2,432
General and administrative	3,083		2,248		4,900		4,206
Sales and marketing	1,028		508		1,608		763
Total stock-based compensation	$	6,671	$	4,221	$	10,664	$	7,730

During the three months ended June 30, 2025 and 2024, total compensation cost capitalized as part of property and equipment and intangible assets was $0.1 million and zero, respectively. During the six months ended June 30, 2025 and 2024, total compensation cost capitalized as part of property and equipment and intangible assets was $0.1 million and zero, respectively.

As of June 30, 2025, total unrecognized stock-based compensation cost, net of estimated forfeitures, related to our unvested stock awards was $52.5 million. This amount is based on an estimated future forfeiture rate of 2.34% per year and will be recognized over a weighted-average period of approximately 3.41 years.

9. COMMITMENTS AND CONTINGENCIES

Lease obligations

The Company primarily enters into leases for office space that are classified as operating leases. During the three months ended June 30, 2025 and 2024, total operating lease costs were $0.5 million and $0.6 million, respectively. Total operating lease costs were $1.0 million for each of the six months ended June 30, 2025 and 2024.

Litigation

From time to time, the Company may become involved in various legal proceedings in the ordinary course of its business and may be subject to third-party infringement claims.

21

In the normal course of business, the Company may agree to indemnify third parties with whom it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company, with respect to certain matters. The Company has agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that the Company’s products, when used for their intended purposes, infringe the intellectual property rights of such other third parties, or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim.

As of June 30, 2025, the Company was not subject to any material litigation or pending litigation claims.

10. NET LOSS PER SHARE

The following tables set forth the computation of the basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2025 and 2024 (in thousands, except share and per share data):

	Three Months Ended June 30,
	2025		2024
Numerator:
Net loss attributable to common stockholders - basic and diluted	$	(167,329)	$	(17,778)
Denominator:
Weighted-average common stock outstanding	302,288,793		172,139,085
Net loss per share attributable to common stockholders - basic and diluted	$	(0.55)	$	(0.10)

	Six Months Ended June 30,
	2025		2024
Numerator:
Net loss attributable to common stockholders - basic and diluted	$	(172,750)	$	(35,090)
Denominator:
Weighted-average common stock outstanding	294,398,419		166,723,787
Net loss per share attributable to common stockholders - basic and diluted	$	(0.59)	$	(0.21)

Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential Common Shares outstanding would have been anti-dilutive.

Potentially dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:

	Six Months Ended June 30,
	2025	2024
Public Warrants as converted to Common Shares (Note 7)	5,387,118	14,420,065
Private Warrants as converted to Common Shares (Note 7)	8,107,302	11,633,060
D-Wave Systems Warrant Preferred Shares as converted to Common Shares (Note 7)	1,155,713	1,155,713
Stock options issued and outstanding	6,776,433	12,966,583
Unvested restricted stock unit awards	10,894,644	10,237,298
Total	32,321,210	50,412,719

22

11. SEGMENT AND GEOGRAPHIC INFORMATION

The Company operates as one operating segment managed on a consolidated basis. The financial information regularly reviewed by the Chief Operating Decision Maker ("CODM") is presented on the same basis as the Company's consolidated financial statements. The measure of profit or loss used by the CODM to allocate resources and assess performance is consolidated net loss. Significant expense categories are not presented, as the expense information regularly provided to the CODM is presented on the same basis as the consolidated statements of operations and comprehensive loss. The CODM relies on consolidated net loss as a comprehensive measure of the Company, considering all revenues and expenses, including cost of revenue, research and development expenses, general and administrative expenses and sales and marketing expenses, to assess the Company’s overall performance and inform strategic decisions on cost control, pricing and investments. Additionally, the CODM also reviews total assets to assess the Company's financial position and resource allocation. The CODM also reviews forward-looking expense information contained in budgets and operating plans to manage operations and allocate resources.

See the condensed consolidated financial statements and accompanying footnotes for consolidated net loss, total expenditures for additions to long-lived assets, total assets and other financial information regarding the Company’s single operating segment. See Note 3 - Revenue from contracts with customers for additional information about revenue by geography.

The following table sets forth the long-lived assets, consisting of property and plant, net, and operating lease right-of-use assets, by geographic area as follows (in thousands):

	As of June 30, 2025		As of December 31, 2024
Canada	$	10,883	$	11,005
United States	470		381
Other	66		8
Total long-lived assets	$	11,419	$	11,394

12. SUBSEQUENT EVENTS

The Company has evaluated all events occurring through August 7, 2025, the date on which the condensed consolidated financial statements were issued, and during which time, nothing has occurred outside the normal course of business operations that would require disclosure except the following:

Lease Agreement

On July 1, 2025, we entered into an operating lease commitment related to one mixed-use office and industrial property adjacent to our Burnaby, BC facility. The lease is expected to commence in the first quarter of 2026. Upon commencement, we expect to recognize aggregate right‑of‑use assets and lease liabilities of approximately $1.0 million.

Warrant Exercises

Subsequent to the end of the quarter, 1,308,658 Warrants were exercised by holders in accordance with the Warrant Agreement. As a result of these exercises, the Company issued 1,902,962 Common Shares. In connection with the exercises, the Company received cash proceeds of $15.0 million.

Equipment Financing Agreement

On August 1, 2025, we entered into an equipment financing agreement. The agreement provides for a total conditional commitment of $13.8 million, with an initial draw of $0.5 million made at execution. The remaining commitment is available until February 1, 2027, which may be extended to August 1, 2027 if at least $11.5 million is drawn by that date. A commitment fee of 1% of the conditional commitment is payable upon the initial draw, and the lender will receive a ten-year warrant to purchase 21,563 Common Shares at an exercise price of $16.05 per share. A non-utilization fee of 3% will apply to the undrawn portion of the first $11.5 million as of the termination date (defined as either February 1, 2027 or August 1, 2027, as applicable).

We will execute one or more equipment financing schedules to evidence each draw. The interest rate for each schedule is based on a spread of approximately 2.2% over the Prime Rate (which was 7.5% at the time of signing) and are fixed at the rate applicable to each respective schedule. However, the rate will not fall below the rate of the initial schedule, which is 9.7%. The lender will hold a first-priority security interest in all financed equipment.

23

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion is intended to assist you in understanding our present business and the results of operations together with our present financial condition. This section should be read in conjunction with our unaudited condensed consolidated financial statements and the accompanying notes contained in Part I, Item I of this Quarterly Report on Form 10-Q (this "Report"), as well as our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the Securities and Exchange Commission on March 14, 2025. In this section, unless otherwise specified, the terms “we”, “our”, “us”, D-Wave" or the "Company" refer to D-Wave Quantum Inc. and its subsidiaries following the closing of the merger between DPCM Capital, Inc. ("DPCM"), D-Wave Systems Inc., and certain other affiliated entities through a series of transactions (the "Merger") on August 5, 2022 (the "Closing") while "D-Wave Systems" refers to D-Wave Systems Inc. prior to the Closing. All other capitalized terms have the meanings ascribed thereto elsewhere in this Report. All dollar amounts are expressed in thousands of United States dollars (“$”), unless otherwise indicated.

Overview

We are a commercial quantum computing company that provides customers with a full suite of professional services and web-based access to our superconducting quantum computer systems, integrated software environment through our LeapTM quantum cloud service, and sells superconducting annealing quantum computer systems. Historically, we have developed our own annealing superconducting quantum computer and associated software, and our current generation quantum system is the D-Wave Advantage2TM system. We are a leader in the development and delivery of quantum computing systems, software and services, and we are the world’s first commercial supplier of quantum computers.

Our business model is focused on generating revenue from providing customers access to our quantum computing systems via the cloud in the form of quantum computing as a service ("QCaaS") products, from providing professional services wherein we assist our customers in identifying and implementing quantum computing applications, as well as selling our quantum computer systems to customers. We have three operating facilities, which we lease, in North America. These facilities are located in Burnaby, British Columbia, Richmond, British Columbia, and Palo Alto, California.

During the three months ended June 30, 2025 and 2024, we generated revenue totaling $3.1 million and $2.2 million, respectively. During the six months ended June 30, 2025 and 2024, we generated revenue totaling $18.1 million and $4.6 million, respectively. We have incurred significant operating losses since inception. For the three months ended June 30, 2025 and 2024, our net losses were $167.3 million and $17.8 million, respectively. For the six months ended June 30, 2025 and 2024, our net losses were $172.8 million and $35.1 million, respectively. We expect to continue to incur significant losses for the foreseeable future as we continue to invest in a number of research and development programs as well as a variety of go-to-market initiatives. As of June 30, 2025, we had an accumulated deficit of $799.7 million.

Macroeconomic Environment

Unfavorable conditions in the economy in the United States, Canada and abroad, including conditions resulting from changes in inflationary pressure, gross domestic product growth, financial and credit market fluctuations, banking collapses and related uncertainty, international trade relations, political turmoil, natural catastrophes, outbreaks of contagious diseases, warfare and terrorist attacks on the United States, Europe or elsewhere, including military actions affecting Russia, Ukraine, Israel or elsewhere, could cause a decrease in business investments in our products and negatively affect the growth of our business and our results of operations. However, to date, these unfavorable conditions have not affected our business.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted, which includes permanent extensions of most expiring Tax Cuts and Jobs Act provisions and international tax changes. The Company is still evaluating the potential impacts of the OBBBA; however, the Company does not anticipate it will have a material impact on the Company’s financial statements.

Key Components of Results of Operations

Revenue

We currently generate our revenue primarily through subscription sales to access our QCaaS cloud platform and professional services related to the development and implementation of quantum computing applications and delivery of quantum computing application training. The Company also sells its superconducting quantum computer systems to customers. QCaaS revenue is recognized on a ratable basis over the contract term, which generally ranges from one month to two years. Professional services revenue is recognized over time on a percentage of completion basis using the costs incurred input measure of progress.

24

Revenue from quantum computing system sales is recognized at a point in time when control transfers to the customer, typically upon delivery or installation, based on the terms of the sales contract. Revenue from system upgrade projects is recognized over time using an input method, measuring progress based on costs incurred to date relative to total estimated costs. This approach is applied to upgrade projects that span multiple reporting periods and meet the criteria for over-time revenue recognition in accordance with ASC 606. Both revenue from quantum computing system sales and revenue from system upgrade projects are classified within system sales in our financial statements.

While we expect that QCaaS revenue would increase both in dollar terms and as a share of total revenue (excluding system sales), as of the end of the period covered by this Form 10-Q, professional services revenue has grown more rapidly—both in dollar terms and as a share of total revenue (excluding system sales). This increase reflects our continued efforts to promote our QCaaS cloud platform by supporting customers through the development and deployment of quantum applications. Customers often engage with our professional service team to gain the knowledge and support needed to effectively use our QCaaS cloud platform. We continue to view professional services as a strategic enabler for long-term QCaaS growth. Meanwhile, quantum computing system revenue may still impact our overall product mix in periods when recognized, although this revenue is expected to remain irregular and intermittent.

Cost of Revenue

Our cost of revenue consists of all direct and indirect expenses related to providing our QCaaS offering and delivering our professional services, such as personnel-related expenses, including stock-based compensation, costs associated with maintaining the cloud platform on which we provide the QCaaS product and depreciation and amortization related to our quantum computing systems and related software.

Cost of revenue for quantum computing systems includes direct manufacturing costs, such as materials and labor for system production, as well as expenses related to installation, warranty, and support. Additionally, it includes shipping and handling costs associated with delivering the systems. These costs are also expensed as incurred.

We expect our total cost of revenue to trend upward in absolute dollars in future periods, corresponding to our anticipated growth in revenue and the higher costs that are necessary to support our customers, maintain the QCaaS cloud offering, operate our quantum computing systems, and deliver our professional services. In the short term, we expect an increase in our cost of revenue as a percentage of total revenue, driven by a higher proportion of professional services, which carry higher delivery costs compared to QCaaS. However, over the long term, we expect this percentage to decline as QCaaS makes up a larger share of our revenue mix, given its lower delivery cost relative to professional services.

Operating Expenses

Our operating expenses consist of research and development, general and administrative, and sales and marketing expenses.

Research and Development

Research and development expenses consist primarily of personnel-related expenses, including salaries, benefits and stock-based compensation for personnel, fabrication costs, lab supplies, and cloud computing resources and allocated facility costs for our research and development functions. Unlike a standard computer, design and development efforts continue throughout the useful life of our quantum computing systems to ensure proper calibration and optimal functionality. Research and development expenses also include purchased hardware components, fabrication and software costs related to quantum computing systems constructed for research purposes that do not have a high probability of providing near-term future economic benefits, and may have no alternate future use. We currently do not capitalize any research and development expenses.

We expect our research and development expenses will trend upward on an absolute dollar basis for the foreseeable future as we continue to invest in research and development efforts to enhance the performance of our annealing quantum computers, further develop our gate model quantum computer, advance our superconducting bump bond process, upgrade our printed circuit board packaging manufacturing, and to broaden the functionality, and improve the reliability, availability and scalability of our QCaaS cloud platform. If in the future we receive government grants and research incentives, which have historically offset a portion of research and development costs, these costs could decrease in absolute dollars. Also, non-cash share based compensation expenses may cause upward and downward fluctuations in these costs from time to time.

General and Administrative

General and administrative expenses consist primarily of personnel-related expenses, including salaries, benefits and stock-based compensation for personnel and outside professional services expenses including legal, audit and accounting services, insurance, other administrative expenses and allocated facility costs for our administrative functions.

25

We expect our general and administrative expenses to increase in absolute dollars for the foreseeable future as we continue to invest in more comprehensive compliance and governance functions, increased IT security and compliance, and expanded internal controls over financial reporting in accordance with the Sarbanes-Oxley Act of 2002. However, non-cash stock-based compensation expenses may cause upward and downward fluctuations in these costs from time to time.

Sales and Marketing

Sales and marketing expenses consist primarily of personnel-related expenses, including salaries, benefits and stock-based compensation for personnel, direct advertising, marketing and promotional material costs, sales commission expense, consulting fees and allocated facility costs for our sales and marketing functions. We intend to continue to make significant investments in our sales and marketing organization to drive additional revenue, expand our global customer base, and broaden our brand awareness. We expect our sales and marketing expenses to continue to increase in absolute dollars for the foreseeable future. However, non-cash stock-based compensation expenses may cause upward and downward fluctuations in these costs from time to time.

Results of Operations

Comparison of the Three Months Ended June 30, 2025 and 2024

The following table sets forth our results of operations for the periods indicated (in thousands):

	Three Months Ended June 30,				Variance
(In thousands, except share and per share data)	2025		2024		Amount		%
Revenue	$	3,095	$	2,183	$	912	42	%
Cost of revenue	1,119		795		324		41	%
Total gross profit	1,976		1,388		588		42	%
Operating expenses:
Research and development	12,694		8,355		4,339		52	%
General and administrative	9,151		7,471		1,680		22	%
Sales and marketing	6,633		4,401		2,232		51	%
Total operating expenses	28,478		20,227		8,251		41	%
Loss from operations	(26,502)		(18,839)		(7,663)		41	%
Other income (expense), net:
Interest expense	(206)		(1,160)		954		(82)	%
Change in fair value of Term Loan	—		(275)		275		(100)	%
Gain (loss) on investment in marketable securities	—		(157)		157		100%
Change in fair value of warrant liabilities	(142,048)		2,195		(144,243)		(6,571)	%
Other income (expense), net	1,427		458		969		212	%
Total other income (expense), net	(140,827)		1,061		(141,888)		(13,373)	%
Net loss	$	(167,329)	$	(17,778)	$	(149,551)	841	%
Foreign currency translation adjustment	787		22		765		3,477	%
Net comprehensive loss	$	(166,542)	$	(17,756)	$	(148,786)	838	%

Revenue

Revenue increased by $0.9 million, or 42%, to $3.1 million for the three months ended June 30, 2025 as compared to $2.2 million for the three months ended June 30, 2024. The increase was primarily driven by revenue from a system upgrade project of $1.0 million and an increase in professional service revenue of $0.4 million, partially offset by a decrease in QCaaS revenue of $0.5 million. Revenue from system upgrade projects is recognized over time using an input method, measuring progress based on costs incurred to date relative to total estimated costs.

Cost of Revenue

Cost of revenue increased by $0.3 million, or 41%, to $1.1 million for the three months ended June 30, 2025 as compared to $0.8 million for the three months ended June 30, 2024. The increase in cost of revenue was primarily due to an increase in infrastructure costs of $0.2 million, system upgrade related costs of $0.1 million and an increase in stock-based compensation expense of $0.1 million.

26

Operating Expenses

Research and Development Expenses

Research and development expenses increased by $4.3 million, or 52%, to $12.7 million for the three months ended June 30, 2025 compared to $8.4 million for the three months ended June 30, 2024. The increase was primarily driven by increases in fabrication costs of $1.6 million, personnel expenses of $1.2 million, stock-based compensation expense of $1.1 million, and professional fees of $0.2 million.

General and Administrative Expenses

General and administrative expenses increased by $1.7 million, or 22%, to $9.2 million for the three months ended June 30, 2025 as compared to $7.5 million for the three months ended June 30, 2024. The increase was primarily driven by increases in professional fees of $1.2 million, personnel expenses of $1.0 million and stock-based compensation expense of $0.8 million, partially offset by decreases in bad debt expenses of $1.2 million, due primarily to recovery of the Zapata Note (see Note 2 - Basis of Presentation and Summary of Significant Accounting Policies and Note 4 - Balance sheet details to the accompanying condensed consolidated financial statements).

Sales and Marketing Expenses

Sales and marketing expenses increased by $2.2 million, or 51%, to $6.6 million for the three months ended June 30, 2025 as compared to $4.4 million for the three months ended June 30, 2024. The increase was primarily driven by increases in personnel costs of $1.3 million, stock-based compensation expense of $0.5 million and marketing expenses of $0.2 million.

Other Income (Expense), net

Interest Expense

Interest expense decreased by $1.0 million, or 82%, to $0.2 million for the three months ended June 30, 2025 as compared to $1.2 million for the three months ended June 30, 2024. The decrease is primarily due to interest expenses related to the Term Loan and Security Agreement ("Term Loan") with PSPIB Unitas Investments II Inc. ("PSPIB" or the "Lender"). The Company fully repaid and extinguished the Term Loan on October 22, 2024, including $30.0 million in principal and $4.3 million in accrued payable in kind ("PIK") interest. Refer to Note 6 - Loans payable, net to the accompanying condensed consolidated financial statements for further details.

Change in fair value of Term Loan

Change in fair value of Term Loan was zero for the three months ended June 30, 2025 as compared to an increase of $0.3 million for the three months ended June 30, 2024. On April 13, 2023, the Company entered into a Term Loan with PSPIB. The Company opted for the fair value option for accounting for the Term Loan (see Note 2 - Basis of Presentation and Summary of Significant Accounting Policies to the accompanying condensed consolidated financial statements). Changes in the fair value of the Term Loan, excluding changes due to the Company's own credit risk, were recorded as gains or losses in the Company’s condensed consolidated statements of operations and comprehensive loss in each reporting period. The fair value of the Term Loan varied primarily based on the market yield rate, market yield volatility and the probabilities of various settlement scenarios. The Company fully repaid and extinguished the Term Loan on October 22, 2024; as a result, no fair value change was recorded for the three months ended June 30, 2025.

Gain on investment in marketable securities

Gain on investment in marketable securities was zero for the three months ended June 30, 2025 as compared to a loss of $0.2 million for the three months ended June 30, 2024. The loss for the three months ended June 30, 2024 resulted from the decrease in fair value of the conversion feature of the Zapata convertible notes (see Note 4 - Balance sheet details to the accompanying condensed consolidated financial statements). There was no similar activity for the three months ended June 30, 2025.

Change in fair value of warrant liabilities

The change in fair value of warrant liabilities was an increase of $142.0 million for the three months ended June 30, 2025 as compared to a decrease of $2.2 million for the three months ended June 30, 2024. The fair value of the warrant liabilities varies primarily with the trading price of the Public Warrants listed on the New York Stock Exchange (see Note 2 - Basis of Presentation and Summary of Significant Accounting Policies and Note 7 - Warrant Liabilities to the accompanying condensed consolidated financial statements). The trading price of the Public Warrants increased during the three months ended June 30, 2025, generally correlated with the appreciation of the Company’s common stock, resulting in a corresponding increase in the fair value of the warrant liabilities.

27

Other income (expense), net

Other income (expense), net increased by $1.0 million or 212%, to a net other expense of $1.4 million for the three months ended June 30, 2025 as compared to net other income of $0.5 million for the three months ended June 30, 2024. The increase was primarily driven by an increase in interest income of $4.1 million due primarily to interest earned on higher cash and cash equivalent balances, partially offset by the impact of net foreign exchange loss of $3.1 million driven by depreciation of the U.S. Dollar against certain foreign currencies.

Comparison of the Six Months Ended June 30, 2025 and 2024

The following table sets forth our results of operations for the periods indicated (in thousands):

	Six Months Ended June 30,				Variance
(In thousands, except share and per share data)	2025		2024		Amount		%
Revenue	$	18,096	$	4,648	$	13,448	289	%
Cost of revenue	2,243		1,601		642		40	%
Total gross profit	15,853		3,047		12,806		420	%
Operating expenses:
Research and development	22,982		16,880		6,102		36	%
General and administrative	17,108		15,037		2,071		14	%
Sales and marketing	13,556		7,485		6,071		81	%
Total operating expenses	53,646		39,402		14,244		36	%
Loss from operations	(37,793)		(36,355)		(1,438)		4	%
Other income (expense), net:
Interest expense	(432)		(2,300)		1,868		(81)	%
Change in fair value of Term Loan	—		924		(924)		(100)	%
Gain (loss) on investment in marketable securities	—		1,503		(1,503)		(100)	%
Change in fair value of warrant liabilities	(138,105)		(457)		(137,648)		30,120	%
Other income (expense), net	3,580		1,595		1,985		124	%
Total other income (expense), net	(134,957)		1,265		(136,222)		(10,769)	%
Net loss	$	(172,750)	$	(35,090)	$	(137,660)	392	%
Foreign currency translation adjustment	1,285		69		1,216		1,762	%
Net comprehensive loss	$	(171,465)	$	(35,021)	$	(136,444)	390	%

Revenue

Revenue increased by $13.4 million, or 289%, to $18.1 million for the six months ended June 30, 2025 as compared to $4.6 million for the six months ended June 30, 2024. The increase was primarily driven by system sales of $13.7 million and an increase in professional service revenue of $0.5 million, partially offset by a decrease in QCaaS revenue of $0.7 million.

Cost of Revenue

Cost of revenue increased by $0.6 million, or 40%, to $2.2 million for the six months ended June 30, 2025 as compared to $1.6 million for the six months ended June 30, 2024. The increase in cost of revenue was primarily due to system sales-related costs of $0.3 million and an increase in infrastructure costs of $0.3 million.

Operating Expenses

Research and Development Expenses

Research and development expenses increased by $6.1 million, or 36%, to $23.0 million for the six months ended June 30, 2025 compared to $16.9 million for the six months ended June 30, 2024. The increase was primarily driven by an increase in fabrication costs of $2.0 million, personnel costs of $1.9 million and stock-based compensation expense of $1.4 million, professional fees of $0.3 million and travel expenses of $0.2 million.

28

General and Administrative Expenses

General and administrative expenses increased by $2.1 million, or 14%, to $17.1 million for the six months ended June 30, 2025 as compared to $15.0 million for the six months ended June 30, 2024. The increase was primarily driven by increases in professional fees of $1.5 million, personnel expenses of $1.3 million and stock-based compensation expense of $0.7 million, partially offset by a decrease in bad debt expenses of $1.3 million, due primarily to recovery of the Zapata Note (see Note 2 - Basis of Presentation and Summary of Significant Accounting Policies and Note 4 - Balance sheet details to the accompanying condensed consolidated financial statements).

Sales and Marketing Expenses

Sales and marketing expenses increased by $6.1 million, or 81%, to $13.6 million for the six months ended June 30, 2025 as compared to $7.5 million for the six months ended June 30, 2024. The increase was primarily driven by increases in personnel costs of $3.4 million, marketing expenses of $1.3 million, stock-based compensation expense of $0.8 million and travel expenses of $0.2 million.

Other Income (Expense), net

Interest Expense

Interest expense decreased by $1.9 million, or 81%, to $0.4 million for the six months ended June 30, 2025 as compared to $2.3 million for the six months ended June 30, 2024. The decrease is primarily due to interest expenses related to the Term Loan and Security Agreement ("Term Loan") with PSPIB Unitas Investments II Inc. ("PSPIB" or the "Lender"). The Company fully repaid and extinguished the Term Loan on October 22, 2024, including $30.0 million in principal and $4.3 million in accrued payable in kind ("PIK") interest. Refer to Note 6 - Loans payable, net to the accompanying condensed consolidated financial statements for further details.

Change in fair value of Term Loan

Change in fair value of Term Loan was zero for the six months ended June 30, 2025 as compared to $0.9 million for the six months ended June 30, 2024. On April 13, 2023, the Company entered into a Term Loan with PSPIB. The Company opted for the fair value option for accounting for the Term Loan (see Note 2 - Basis of Presentation and Summary of Significant Accounting Policies to the accompanying condensed consolidated financial statements). Changes in the fair value of the Term Loan, excluding changes due to the Company's own credit risk, were recorded as gains or losses in the Company’s condensed consolidated statements of operations and comprehensive loss in each reporting period. The fair value of the Term Loan varied primarily based on the market yield rate, market yield volatility and the probabilities of various settlement scenarios. The Company fully repaid and extinguished the Term Loan on October 22, 2024; as a result, no fair value change was recorded for the six months ended June 30, 2025.

Gain on investment in marketable securities

Gain on investment in marketable securities was zero for the six months ended June 30, 2025 as compared to $1.5 million for the six months ended June 30, 2024. On January 5, 2024, an investee of the Company was acquired for a combination of cash and stock in an observable orderly transaction. Consequently, the carrying value of the Company's investment was adjusted based on the consideration received, resulting in a net gain of $1.7 million, partially offset by a loss associated with the fair value of the conversion feature of the Zapata Note. There was no similar activity for the six months ended June 30, 2025.

Change in fair value of warrant liabilities

The change in fair value of warrant liabilities was an increase of $138.1 million for the six months ended June 30, 2025 as compared to an increase of $0.5 million for the six months ended June 30, 2024. The fair value of the warrant liabilities varies primarily with the trading price of the Public Warrants listed on the New York Stock Exchange (see Note 2 - Basis of Presentation and Summary of Significant Accounting Policies and Note 7 - Warrant Liabilities to the accompanying condensed consolidated financial statements). The trading price of the Public Warrants increased during the six months ended June 30, 2025, generally in line with the appreciation of the Company’s common stock, resulting in a corresponding increase in the fair value of the warrant liabilities.

Other income (expense), net

Other income (expense), net increased by $2.0 million or 124%, to a net other income of $3.6 million for the six months ended June 30, 2025 as compared to a net other income of $1.6 million for the six months ended June 30, 2024. The increase was primarily driven by an increase in interest income of $6.9 million due primarily to interest earned on higher cash and cash equivalent balances, partially offset by the impact of net foreign exchange loss of $4.9 million driven by depreciation of the U.S. Dollar against certain foreign currencies.

29

Liquidity and Capital Resources

Lincoln Park Purchase Agreement

In conjunction with the Merger with DPCM, the Company and D-Wave Systems entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("Lincoln Park") on June 16, 2022 (the "Purchase Agreement") which provided D-Wave the sole right, but not the obligation, to direct Lincoln Park to buy specified dollar amounts up to $150 million of D-Wave's common stock, par value $0.0001 per share through November 1, 2025. The Purchase Agreement provided the Company with additional liquidity to fund the business, subject to the conditions set forth in the agreement, including volume limitations tied to periodic market prices, ownership limitations restricting Lincoln Park from owning more than 9.9% of the then total outstanding shares of common stock of the Company, par value $0.0001 (the "Common Shares") and a floor price of $1.00 at or below which the Company could not sell to Lincoln Park any Common Shares. For shares sold by the Company to Lincoln Park, Lincoln Park may resell all, some, or none of those Common Shares at any time or from time to time in its sole discretion. In order for the Company to issue Common Shares under the Purchase Agreement, the Company's share price was required to be above the floor price of $1.00. During the six months ended June 30, 2025, the Company issued 3,873,113 Common Shares to Lincoln Park under the Purchase Agreement, resulting in $37.8 million of net proceeds. As of June 30, 2025, D-Wave had completed 100% of the issuances available under the Purchase Agreement.

At-the-Market Offerings

On May 24, 2024, the Company entered into an at-the-market sales agreement (the "$100M ATM") with Needham & Company, LLC, B. Riley Securities, Inc., and Roth Capital Partners, LLC (the "$100M ATM Agents"). Under this agreement, the Company could sell shares of its common stock with an aggregate offering price of up to $100.0 million through or to the $100M ATM Agents. During the year ended December 31, 2024, the Company received $97.2 million in net proceeds through the issuance of 49,812,287 Common Shares. As of June 30, 2025, D-Wave had completed 100% of the issuances available under the $100M ATM.

On December 9, 2024, the Company entered into a new at-the-market sales agreement (the "$75M ATM") with Needham & Company, LLC, Roth Capital Partners, LLC, B. Riley Securities, Inc., and Craig-Hallum Capital Group, LLC (the "$75M ATM Agents"). Under this agreement, the Company could sell shares of its common stock with an aggregate offering price of up to $75.0 million through or to the $75M ATM Agents. During the year ended December 31, 2024, the Company received $72.9 million in net proceeds through the issuance of 15,576,628 Common Shares. As of June 30, 2025, D-Wave had completed 100% of the issuances available under the $75M ATM.

On January 10, 2025, the Company entered into another at-the-market sales agreement (the "$150M ATM") with Needham & Company, LLC, Stifel, Nicolaus & Company, Incorporated, B. Riley Securities, Inc., Roth Capital Partners, LLC, The Benchmark Company, LLC, and Craig-Hallum Capital Group, LLC (the "$150M ATM Agents"). Under this agreement, the Company could sell shares of its common stock with an aggregate offering price of up to $150.0 million through or to the $150M ATM Agents. As of June 30, 2025, the Company has received $146.1 million in net proceeds through the issuance of 24,604,021 Common Shares. As of June 30, 2025, D-Wave had completed 100% of the issuances available under the $150M ATM.

On June 10, 2025, the Company entered into another at-the-market sales agreement (the "$400M ATM") with Needham & Company, LLC, Evercore Group L.L.C., TD Securities (USA) LLC, Canaccord Genuity LLC, Mizuho Securities USA LLC, Piper Sandler & Co., Craig-Hallum Capital Group LLC and Rosenblatt Securities Inc. (collectively, the “$400M ATM Agents”). Under this agreement, the Company could sell shares of its common stock with an aggregate offering price of up to $400.0 million through or to the $400M ATM Agents. As of June 30, 2025, the Company has received $390.6 million in net proceeds through the issuance of 26,344,831 Common Shares. As of June 30, 2025, D-Wave had completed 100% of the issuances available under the $400M ATM.

Sales under these agreements are classified as "at-the-market" equity offerings under Rule 415(a)(4) of the Securities Act and may be conducted on the NYSE or other trading platforms. The $100M ATM Agents, $75M ATM Agents, $150M ATM Agents and $400M ATM Agents (collectively, the "Agents") used commercially reasonable efforts to sell shares based on the Company’s instructions. The compensation to the Agents was up to 3.0% of the gross sales price, along with expense reimbursements. The Company has also agreed to provide indemnification against certain liabilities under the Securities Act.

The Company was not obligated to sell shares under any of these agreements. Each agreement could have been terminated by: (a) the election of the applicable Agents upon the occurrence of certain adverse events, (b) five business days’ advance notice from the Company to the applicable Agents or five days’ advance notice from any of the applicable Agents to the Company or (c) otherwise by mutual agreement of the parties pursuant to the terms of the applicable sales agreement.

30

Warrant exercises

During the six months ended June 30, 2025, 8,636,509 Warrants were exercised by holders in accordance with the terms of the Warrant Agreement. As a result of these exercises, the Company issued 12,558,471 Common Shares, in exchange for cash proceeds of $99.3 million.

Repayment of the Term Loan

In addition, we successfully repaid a significant portion of our outstanding debt obligations, including the Term Loan with PSPIB, a related party to a major shareholder of the Company as of December 31, 2024, that was initially entered into on April 13, 2023 (the "Closing Date"). The Term Loan, outlined in Note 6 - Loans payable, net to the condensed consolidated financial statements, provided for $50.0 million in three tranches, subject to certain terms and conditions. The Company drew down two tranches totaling $30.0 million and, on October 22, 2024, the Company had prepaid the entire Term Loan, including $30.0 million in principal and $4.3 million in accrued PIK interest.

Cash Flows

The following table sets forth our cash flows for the periods indicated (in thousands):

	Six Months Ended June 30,
	2025		2024
Net cash provided by (used in):
Operating Activities	$	(34,565)	$	(26,587)
Investing Activities	(357)		(1,809)
Financing Activities	674,969		27,881
Effect of exchange rate changes on cash and cash equivalents	1,285		69
Net increase (decrease) in cash and cash equivalents	$	641,332	$	(446)

Cash Flows Used in Operating Activities

Our cash flows from operating activities are significantly affected by the growth of our business, and are primarily related to research and development, sales and marketing and general and administrative activities. Our operating cash flows are also affected by our working capital needs to support growth in personnel-related expenditures and fluctuations in accounts payable, accounts receivable and other current assets and liabilities.

For the six months ended June 30, 2025, net cash used in operating activities was $34.6 million, an increase of $8.0 million from $26.6 million for the six months ended June 30, 2024. The change is primarily due to an increase in noncash items added back to net loss of $144.9 million, offset by an increase in net loss of $137.7 million and a decrease in cash absorbed by working capital of $15.2 million (primarily related to recognition of deferred revenue). The increase in noncash items was primarily due to an increase in change in fair value of warrant liabilities of $137.6 million, an increase in unrealized foreign exchange loss of $3.3 million and an increase in stock-based compensation of $2.9 million. The decrease in cash absorbed by working capital was primarily driven by an increased change in deferred revenue of $13.7 million and an increased change in prepaid expenses and other current assets.

Cash Flows Used in Investing Activities

Net cash used in investing activities during the six months ended June 30, 2025 was $0.4 million, a decrease of $1.5 million from $1.8 million for the six months ended June 30, 2024. The decrease primarily reflects the absence of a $1.0 million purchase of a convertible note, partially offset by the absence of $0.3 million in proceeds from sales of marketable securities and an increase in purchase of property and equipment of $0.3 million. Both the purchase of a convertible note and sales of marketable securities occurred during the six months ended June 30, 2024, but not in the current period.

Cash Flows Provided by Financing Activities

Net cash provided by financing activities during the six months ended June 30, 2025 was $675.0 million, an increase of $647.1 million from $27.9 million for the six months ended June 30, 2024. The increase is primarily due to an increase in proceeds from the issuance of common stock pursuant to at-the-market offerings of $527.6 million, an increase in proceeds from issuance of common stock upon exercise of Warrants of $99.3 million, an increase in proceeds from the issuance of common stock pursuant to the Purchase Agreement with Lincoln Park of $17.5 million and an increase in proceeds from the issuance of common stock upon exercise of stock options of $6.8 million, partially offset by an increase in payment of tax withheld pursuant to stock-based compensation settlements of $4.3 million.

31

Contractual Obligations and Commitments

As of June 30, 2025, there have been no material changes with regard to contractual obligations from those disclosed in our "Management's Discussion and Analysis on Financial Condition and Results of Operations—Contractual Obligations and Commitments" in our Annual Report on Form 10-K for the year ended December 31, 2024.

Critical Accounting Estimates

Except as noted below, there have been no material changes to our critical accounting policies from those disclosed in the “Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates” section of our Annual Report on Form 10-K for the year ended December 31, 2024.

Revenue from system upgrade projects is recognized over time using an input method, measuring progress based on costs incurred to date relative to total estimated costs. This method is applied to upgrade projects that span multiple reporting periods and meet the over-time revenue recognition criteria under ASC 606. The estimation of total project costs requires significant judgment and is based on various factors, including historical cost experience, anticipated labor productivity, and the complexity of the work to be performed. These cost estimates are reassessed regularly throughout the life of the project, and any changes in estimates are accounted for in the period in which the change is identified. Revisions to total estimated costs can affect the amount and timing of revenue recognized, and may result in cumulative catch-up adjustments to revenue in the period of change. If estimates indicate that a contract will result in a loss, the entire estimated loss is recognized immediately in cost of revenue.

Recently Issued and Adopted Accounting Standards

A discussion of recent accounting pronouncements issued and adopted is included in Note 2 - Basis of Presentation and Summary of Significant Accounting Policies to our unaudited condensed consolidated financial statements included elsewhere in this Report.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable to Smaller Reporting Companies.

32

Item 4. Controls and Procedures

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (2) accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of June 30, 2025, our disclosure controls and procedures were effective in providing reasonable assurance that information required to be disclosed in our reports filed under the Exchange Act was recorded, processed, summarized and reported within the time periods prescribed by SEC rules and regulations, and that such information was accumulated and communicated to our management to allow timely decisions regarding required disclosure. Accordingly, we believe that the consolidated financial statements included in this Form 10-Q do fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented.

Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act), during the three months ended June 30, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Part II - Other Information

Item 1. Legal Proceedings

From time to time, we may become involved in legal proceedings arising in the ordinary course of business. There are currently no pending or threatened legal proceedings or claims against us that, in our opinion, are likely to have a material adverse effect on our business, operating results, financial condition or cash flows. Defending such proceedings is costly and can impose a significant burden on management and team members. The results of any future litigation cannot be predicted with certainty, but regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Item 1A. Risk Factors

There have been no material changes from the risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on March 14, 2025, with the exception of the risk factor discussed below.

We will no longer qualify as an “emerging growth company” or a “smaller reporting company” as of December 31, 2025 and, as a result, we will no longer be able to avail ourselves of certain reduced disclosure requirements applicable to emerging growth companies and smaller reporting companies.

We are currently an “emerging growth company”, as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"). As such, we are eligible for, and intend to take advantage of, certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies for as long as we continue to be an emerging growth company, including:

•the exemption from the auditor attestation requirements with respect to internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act;

•the exemptions from say-on-pay, say-on-frequency and say-on-golden parachute voting requirements; and

33

•reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements.

In addition, Section 107 of the JOBS Act provides that an emerging growth company may take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. Therefore, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected to avail ourselves of this extended transition period and, as a result, we will not adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies, until such time that we no longer qualify as an emerging growth company.

We are also currently a “smaller reporting company,” as defined in Rule 12b-2 under the Exchange Act. Similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations, such as an ability to provide simplified executive compensation information and only two years of audited financial statements in an Annual Report on Form 10-K, with correspondingly reduced “Management’s Discussion and Analysis of Financial Condition and Results of Operations” disclosure. We may take advantage of certain of the scaled disclosures available to smaller reporting companies in our next annual report on Form 10-K for the period ending December 31, 2025.

Investors may find our securities less attractive to the extent that we rely on these exemptions, which may result in a less active trading market for the Common Shares and the price of the Common Shares may be more volatile.

We will be deemed a "large accelerated filer" under the Exchange Act as of December 31, 2025 because the market value of our Common Shares held by non-affiliates exceeded $700 million as of June 30, 2025. In addition, our fifth anniversary of the date of the first sale of common equity securities pursuant to an effective Securities Act registration statement will occur in October 2025. As a result, we will cease to qualify as an emerging growth company as of December 31, 2025, and as such, we will no longer be able to take advantage of any of the exemptions from various reporting requirements that are applicable to emerging growth companies effective as of December 31, 2025.

In addition, based on the market value of our Common Shares held by non-affiliates as of June 30, 2025, we will no longer be able to take advantage of any of the exemptions from various reporting requirements that are applicable to smaller reporting companies beginning with our quarterly report on Form 10-Q for the quarterly period ending March 31, 2026.

We expect that the loss of our emerging growth company and smaller reporting company statuses and compliance with various additional reporting requirements will increase our legal and financial compliance costs. If these additional reporting requirements divert the attention of our management and personnel from other business concerns, or if we fail to comply with these additional requirements in a timely manner, or at all, our business and results of operations could be harmed and the trading price of our Common Shares may decline.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Securities Trading Plans of Directors and Executive Officers

From time to time, some of the Company’s directors or executive officers may determine that it is advisable to diversify their investments for personal financial planning reasons or may seek liquidity for other reasons and may sell shares of common stock of the Company. To effect such sales, from time to time, some of the Company’s executive officers or directors may enter into trading plans that are designed to comply with the Company’s Amended and Restated Securities Trading Policy and intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act.

During the three months ended June 30, 2025, the following directors of the Company each adopted a "Rule 10b5-1 trading arrangement", as such term is defined under Item 408 of Regulation S-K:

34

Name of Director	Date of Adoption	Expiration Date of Trading Arrangement1	Aggregate Number of Securities to be Sold
Rohit Ghai	June 13, 2025	June 30, 2026	Up to 43,518 shares of common stock issuable upon vesting of restricted stock units
John DiLullo	June 15, 2025	December 31, 2026	Up to 34,050 shares of common stock issuable upon vesting of restricted stock units

1 The trading arrangement may end earlier if all transactions under the trading arrangement are completed prior to the expiration date.

During the three months ended June 30, 2025, none of the Company's other directors or officers adopted a "Rule 10b5-1 trading arrangement, and none of the Company’s directors or officers modified or terminated a “Rule 10b5-1 trading arrangement” or adopted, modified, or terminated a “non-Rule 10b5-1 trading arrangement”, as such terms are defined under Item 408 of Regulation S-K.

35

Item 6. Exhibits

Exhibit No.	Description	Incorporated by Reference Exhibits
		Filer	Form	Exhibit	Filing Date
10.1#	D-Wave Quantum Inc. Severance Policy.	D-Wave Quantum Inc.	8-K	10.1	May 7, 2025
10.2#	Form of Participation Agreement pursuant to the D-Wave Quantum Inc. Severance Policy.	D-Wave Quantum Inc.	8-K	10.2	May 7, 2025
10.3#	Second Amendment to Amended and Restated Employment Agreement, effective May 6, 2025, by and between D-Wave Quantum Inc. and Alan Baratz.	D-Wave Quantum Inc.	8-K	10.3	May 7, 2025
10.4#	Third Amendment to Employment Agreement, effective May 6, 2025, by and between D-Wave Quantum Inc. and John Markovich.	D-Wave Quantum Inc.	8-K	10.4	May 7, 2025
10.5#	Third Amendment to Amended and Restated Employment Agreement effective May 6, 2025, by and between D-Wave Quantum Inc. and Diane Nguyen.	D-Wave Quantum Inc.	8-K	10.5	May 7, 2025
31.1*	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.
31.2*	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.
32.1**	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	Inline XBRL Instance Document.
101.SCH*	Inline XBRL Taxonomy Extension Schema Document.
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	Inline XBRL Taxonomy Extension Labels Linkbase Document.
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

#    Indicates management contract or compensatory plan or arrangement.

*    Filed herewith.

**    Furnished with this report in accordance with Item 601(b)(32) of Regulation S-K, this exhibit is not deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act, except to the extent that the registrant specifically incorporates it by reference.

36

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	D-Wave Quantum Inc.
August 7, 2025	By:	/s/ John M. Markovich
		John M. Markovich
		Chief Financial Officer
		(Principal Financial and Accounting Officer and Duly Authorized Officer)

37

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Alan Baratz, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of D-Wave Quantum Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: August 7, 2025	By:	/s/ Alan Baratz
		Alan Baratz
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, John M. Markovich, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of D-Wave Quantum Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: August 7, 2025	By:	/s/ John M. Markovich
		John M. Markovich
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of D-Wave Quantum Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Alan Baratz, President & Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 7, 2025	By:	/s/ Alan Baratz
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of D-Wave Quantum Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John M. Markovich, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 7, 2025	By:	/s/ John M. Markovich
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

XML

Cover - shares	6 Months Ended
	Jun. 30, 2025	Aug. 05, 2025
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2025
Document Transition Report	false
Entity File Number	001-41468
Entity Registrant Name	D-WAVE QUANTUM INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	88-1068854
Entity Address, Address Line One	2650 East Bayshore Road
Entity Address, City or Town	Palo Alto
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94303
City Area Code	604
Local Phone Number	630-1428
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		338,605,149
Entity Central Index Key	0001907982
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q2
Amendment Flag	false
Common stock, par value $0.0001 per share
Document Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	QBTS
Security Exchange Name	NYSE
Warrants, each whole warrant exercisable for 1.4541326 shares of common stock at an exercise price of $11.50
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for 1.4541326 shares of common stock at an exercise price of $11.50
Trading Symbol	QBTS.WT
Security Exchange Name	NYSE

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 819,312	$ 177,980
Trade accounts receivable, net of allowance for doubtful accounts of $1 and $176	1,442	1,420
Inventories	2,448	1,686
Prepaid expenses and other current assets	5,338	3,954
Total current assets	828,540	185,040
Property and equipment, net	4,504	4,133
Operating lease right-of-use assets	6,915	7,261
Intangible assets, net	586	490
Other non-current assets, net	3,057	2,929
Total assets	843,602	199,853
Current liabilities:
Trade accounts payable	1,190	815
Accrued expenses and other current liabilities	11,582	8,784
Current portion of operating lease liabilities	1,596	1,512
Loans payable, net, current	0	348
Deferred revenue, current	4,906	18,686
Total current liabilities	19,274	30,145
Warrant liabilities	91,037	69,875
Operating lease liabilities, net of current portion	6,322	6,389
Loans payable, net, non-current	32,061	30,128
Deferred revenue, non-current	654	670
Total liabilities	149,348	137,207
Commitments and contingencies (Note 9)
Stockholders' equity:
Common stock, par value $0.0001 per share; 675,000,000 shares authorized at both June 30, 2025 and December 31, 2024; 339,837,650 shares and 266,595,867 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively.	33	27
Additional paid-in capital	1,503,136	700,069
Accumulated deficit	(799,690)	(626,940)
Accumulated other comprehensive loss	(9,225)	(10,510)
Total stockholders' equity	694,254	62,646
Total liabilities and stockholders’ equity	$ 843,602	$ 199,853

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Statement of Financial Position [Abstract]
Trade accounts receivable, net of allowance for doubtful accounts	$ 1	$ 176
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	675,000,000	675,000,000
Common stock, issued (in shares)	339,837,650	266,595,867
Common stock, outstanding (in shares)	339,837,650	266,595,867

XML

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Revenue	$ 3,095	$ 2,183	$ 18,096	$ 4,648
Cost of revenue	1,119	795	2,243	1,601
Total gross profit	1,976	1,388	15,853	3,047
Operating expenses:
Research and development	12,694	8,355	22,982	16,880
General and administrative	9,151	7,471	17,108	15,037
Sales and marketing	6,633	4,401	13,556	7,485
Total operating expenses	28,478	20,227	53,646	39,402
Loss from operations	(26,502)	(18,839)	(37,793)	(36,355)
Other income (expense), net:
Interest expense	(206)	(1,160)	(432)	(2,300)
Change in fair value of Term Loan	0	(275)	0	924
Gain (loss) on investment in marketable securities	0	(157)	0	1,503
Change in fair value of warrant liabilities	(142,048)	2,195	(138,105)	(457)
Other income (expense), net	1,427	458	3,580	1,595
Total other income (expense), net	(140,827)	1,061	(134,957)	1,265
Net loss	$ (167,329)	$ (17,778)	$ (172,750)	$ (35,090)
Net loss per share, basic (in usd per share)	$ (0.55)	$ (0.10)	$ (0.59)	$ (0.21)
Net loss per share, diluted (in usd per share)	$ (0.55)	$ (0.10)	$ (0.59)	$ (0.21)
Weighted-average shares used in computing net loss per share, basic (in shares)	302,288,793	172,139,085	294,398,419	166,723,787
Weighted-average shares used in computing net loss per share, diluted (in shares)	302,288,793	172,139,085	294,398,419	166,723,787
Comprehensive loss:
Net loss	$ (167,329)	$ (17,778)	$ (172,750)	$ (35,090)
Foreign currency translation adjustment	787	22	1,285	69
Net comprehensive loss	$ (166,542)	$ (17,756)	$ (171,465)	$ (35,021)

XML

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Lincoln Park Purchase Agreement	At-the-Market Offering	Common stock	Common stock Lincoln Park Purchase Agreement	Common stock At-the-Market Offering	Additional paid-in capital	Additional paid-in capital Lincoln Park Purchase Agreement	Additional paid-in capital At-the-Market Offering	Accumulated deficit	Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2023				161,113,744
Beginning balance at Dec. 31, 2023	$ (24,481)			$ 16			$ 469,081			$ (483,061)	$ (10,517)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with the Purchase Agreement/ATM agreement (in shares)					14,948,550
Issuance of common stock in connection with the Purchase Agreement/ATM agreement		$ 20,288			$ 1			$ 20,287
Issuance of common stock in connection with the Employee Stock Purchase Plan (in shares)				262,777
Issuance of common stock in connection with the Lincoln Park Purchase Agreement	171						171
Issuance of common stock in connection with exercise of stock options and vesting of RSUs (in shares)						8,279,098
Issuance of common stock in connection with exercise of stock options and vesting of RSUs			$ 9,101			$ 1			$ 9,100
Issuance of common stock under stock-based compensation plans (in shares)				1,468,918
Issuance of common stock under stock-based compensation plans	43						43
Stock-based compensation	9,736						9,736
Tax withholding related to vesting of restricted stock units	(1,351)						(1,351)
Foreign currency translation adjustment, net of tax	69										69
Net loss	(35,090)									(35,090)
Ending balance (in shares) at Jun. 30, 2024				186,073,087
Ending balance at Jun. 30, 2024	(21,514)			$ 18			507,067			(518,151)	(10,448)
Beginning balance (in shares) at Mar. 31, 2024				161,675,010
Beginning balance at Mar. 31, 2024	(36,957)			$ 16			473,870			(500,373)	(10,470)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with the Purchase Agreement/ATM agreement (in shares)					14,948,550	8,279,098
Issuance of common stock in connection with the Purchase Agreement/ATM agreement		20,288	9,101		$ 1	$ 1		20,287	9,100
Issuance of common stock in connection with the Employee Stock Purchase Plan (in shares)				262,777
Issuance of common stock in connection with the Lincoln Park Purchase Agreement	171						171
Issuance of common stock under stock-based compensation plans (in shares)				907,652
Issuance of common stock under stock-based compensation plans	35						35
Stock-based compensation	4,221						4,221
Tax withholding related to vesting of restricted stock units	(617)						(617)
Foreign currency translation adjustment, net of tax	22										22
Net loss	(17,778)									(17,778)
Ending balance (in shares) at Jun. 30, 2024				186,073,087
Ending balance at Jun. 30, 2024	$ (21,514)			$ 18			507,067			(518,151)	(10,448)
Beginning balance (in shares) at Dec. 31, 2024	266,595,867			266,595,867
Beginning balance at Dec. 31, 2024	$ 62,646			$ 27			700,069			(626,940)	(10,510)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with the Purchase Agreement/ATM agreement (in shares)					3,873,113	50,948,852
Issuance of common stock in connection with the Purchase Agreement/ATM agreement		37,787	536,741			$ 5		37,787	536,736
Issuance of common stock in connection with the Employee Stock Purchase Plan (in shares)				95,331
Issuance of common stock in connection with the Lincoln Park Purchase Agreement	291						291
Issuance of common stock in connection with exercise of stock options and vesting of RSUs (in shares)				5,766,016
Issuance of common stock in connection with exercise of stock options and vesting of RSUs	6,860						6,860
Issuance of common stock in connection with exercise of warrants (in shares)				12,558,471
Issuance of common stock in connection with exercise of warrants	216,262			$ 1			216,261
Stock-based compensation	10,796						10,796
Tax withholding related to vesting of restricted stock units	(5,664)						(5,664)
Foreign currency translation adjustment, net of tax	1,285										1,285
Net loss	$ (172,750)									(172,750)
Ending balance (in shares) at Jun. 30, 2025	339,837,650			339,837,650
Ending balance at Jun. 30, 2025	$ 694,254			$ 33			1,503,136			(799,690)	(9,225)
Beginning balance (in shares) at Mar. 31, 2025				291,351,403
Beginning balance at Mar. 31, 2025	207,389			$ 29			849,733			(632,361)	(10,012)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with the Purchase Agreement/ATM agreement (in shares)					3,873,113	26,344,831
Issuance of common stock in connection with the Purchase Agreement/ATM agreement		$ 37,787	$ 390,633			$ 3		$ 37,787	$ 390,630
Issuance of common stock in connection with the Employee Stock Purchase Plan (in shares)				95,331
Issuance of common stock in connection with the Lincoln Park Purchase Agreement	291						291
Issuance of common stock in connection with exercise of stock options and vesting of RSUs (in shares)				5,614,895
Issuance of common stock in connection with exercise of stock options and vesting of RSUs	6,837						6,837
Issuance of common stock in connection with exercise of warrants (in shares)				12,558,077
Issuance of common stock in connection with exercise of warrants	216,256			$ 1			216,255
Stock-based compensation	6,750						6,750
Tax withholding related to vesting of restricted stock units	(5,147)						(5,147)
Foreign currency translation adjustment, net of tax	787										787
Net loss	$ (167,329)									(167,329)
Ending balance (in shares) at Jun. 30, 2025	339,837,650			339,837,650
Ending balance at Jun. 30, 2025	$ 694,254			$ 33			$ 1,503,136			$ (799,690)	$ (9,225)

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net loss	$ (172,750,000)	$ (35,090,000)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	714,000	510,000
Stock-based compensation	10,664,000	7,730,000
Amortization of operating right-of-use assets	346,000	398,000
Non-cash interest expense	387,000	2,211,000
Change in fair value of Warrant liabilities	138,105,000	457,000
Change in fair value of Term Loan	0	(924,000)
Gain on marketable securities	0	(1,503,000)
Unrealized foreign exchange loss (gain)	1,998,000	(1,274,000)
Other noncash items	267,000	0
Change in operating assets and liabilities:
Trade accounts receivable	(57,000)	9,000
Inventories	(762,000)	(147,000)
Prepaid expenses and other current assets	(1,368,000)	(339,000)
Trade accounts payable	416,000	(502,000)
Accrued expenses and other current liabilities	2,695,000	1,741,000
Deferred revenue	(13,796,000)	(125,000)
Operating lease liability	(344,000)	364,000
Other non-current assets, net	(1,080,000)	(103,000)
Net cash used in operating activities	(34,565,000)	(26,587,000)
Cash flows from investing activities:
Purchase of property and equipment	(1,187,000)	(850,000)
Purchase of convertible note (Note 4)	0	(1,000,000)
Proceeds from recovery of previously written-off note receivable (Note 4)	959,000	0
Sales of marketable securities (Note 4)	0	254,000
Expenditures for internal-use software	(129,000)	(213,000)
Net cash used in investing activities	(357,000)	(1,809,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock pursuant to the Lincoln Park Purchase Agreement	37,787,000	20,288,000
Proceeds from the issuance of common stock in at-the-market offerings, net of issuance costs	536,741,000	9,100,000
Proceeds from issuance of common stock upon exercise of warrants	99,319,000	0
Proceeds from the issuance of common stock upon exercise of stock options	6,860,000	43,000
Proceeds from common stock issued under the Employee Stock Purchase Plan	291,000	171,000
Payment of tax withheld pursuant to stock-based compensation settlements	(5,664,000)	(1,351,000)
Repayments on TPC loan	(365,000)	(370,000)
Net cash provided by financing activities	674,969,000	27,881,000
Effect of exchange rate changes on cash and cash equivalents	1,285,000	69,000
Net increase (decrease) in cash and cash equivalents	641,332,000	(446,000)
Cash and cash equivalents at beginning of period	177,980,000	41,307,000
Cash and cash equivalents at end of period	819,312,000	40,861,000
Supplemental disclosure of non-cash investing and financing activities:
Capitalized stock-based compensation	132,000	0
Reclassification of warrant liability to equity upon exercise	116,943,000	0
Operating lease right-of-use assets exchanged for new operating lease obligations	0	476,000
Purchases of property and equipment included in accounts payable	0	239,000
Bonus settled in vested share based compensation awards	$ 0	$ 2,006,000

XML

DESCRIPTION OF BUSINESS

6 Months Ended

Jun. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

DESCRIPTION OF BUSINESS

1. DESCRIPTION OF BUSINESS

D-Wave Quantum Inc. ("D-Wave" or the “Company”) was incorporated as a corporation organized and existing under the General Corporation Law of the State of Delaware on January 24, 2022. The Company was formed for the purpose of effecting a merger between DPCM Capital, Inc. (“DPCM”), D-Wave Systems Inc. (“D-Wave Systems”), and certain other affiliated entities through a series of transactions (the “Merger”) pursuant to the definitive agreement entered into on February 7, 2022 (the “Transaction Agreement”). On August 5, 2022, in conjunction with the Merger, DPCM and D-Wave Systems became wholly-owned subsidiaries of, and are operated by, the Company. Upon the completion of the Merger, the Company succeeded to all of the operations of its predecessor, D-Wave Systems.

D-Wave is a commercial quantum computing company that provides customers with a full suite of professional services and web-based access to its superconducting quantum computer systems and integrated software environment through the LeapTM quantum cloud service. The Company also sells its superconducting quantum computer systems to customers. Historically, the Company has developed its own annealing superconducting quantum computer and associated software, with its current sixth-generation quantum computing system being the Advantage2TM.

D-Wave has three operating facilities, which it leases, in North America. These facilities are located in Burnaby, British Columbia, Richmond, British Columbia, and Palo Alto, California.

XML

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Jun. 30, 2025

Accounting Policies [Abstract]

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The unaudited interim condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosure normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the United States Securities and Exchange Commission ("SEC"). In the opinion of the Company, the unaudited financial information for the interim periods presented reflects all adjustments, which are normal and recurring, necessary for a fair presentation of the condensed consolidated balance sheets, condensed consolidated statements of operations and comprehensive loss, and condensed consolidated statements of cash flows. Interim results should not be regarded as indicative of results that may be expected for any other period or the entire year.

The interim condensed consolidated financial statements included herein have been prepared on the same basis as the audited annual consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K as of and for the year ended December 31, 2024 filed with the SEC on March 14, 2025.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in the condensed consolidated financial statements upon consolidation.

Use of estimates

The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. The most significant estimates and assumptions are used in determining: (i) inputs used to recognize revenue over time relating to hours estimated to complete the remaining performance obligations, (ii) fair value of financial instruments, and (iii) long term revenue forecasts used in the accounting for the SIF Loan (see below and Note 6 for further information). These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.

The Company’s accounting estimates and assumptions may change over time in response to risks and uncertainties, including uncertainty in the current economic environment due to inflation, tariffs, changes in interest rates and monetary policy, various geopolitical conflicts, and any evolutions thereof. The change could be material in future periods. As of the date of issuance of these condensed consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.

Investment in securities

The Company holds investments in the equity securities of privately held companies, which are valued based on their original cost. Adjustments are made for observable price changes in orderly transactions involving identical or similar securities of the same issuer, as there are no quoted market prices available.

The Company also held an investment in a convertible note (the "Note") of Zapata Computing, Inc. ("Zapata"). The Company accounted for the Note as a loan receivable pursuant to ASC 310, as the Note did not meet the definition of a security. On April 1, 2024, Zapata stock began trading on the Nasdaq Stock Market and as such became readily convertible to cash. The Company then bifurcated the conversion feature at fair value.

On October 11, 2024, Zapata announced that it was insolvent and would cease operations. Considering this and other financial information available prior to the balance sheet date as of December 31, 2024, the Note was provisionally determined to be uncollectible, and the Company has recognized a credit loss provision for the entire balance owed of $1.0 million as of December 31, 2024. The charge was recorded within general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss.

The Company was one of two senior-most secured creditors to Zapata. The Note was secured by substantially all of Zapata's assets, including cash accounts, accounts receivables, inventory, contract rights and general intangibles, intellectual property, and equipment, as set forth in the security agreements pertaining to the Note.

Subsequent to the write-off of the Note, in June 2025, the Company recovered the full principal balance of the Note, along with $0.2 million in interest and $0.1 million in legal fees. The recovery was recorded within general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss, offsetting the previously recorded credit loss provision and legal expenses. The cash received for the principal balance of the Note is presented within investing activities in the statement of cash flows. The interest was recorded within interest income (expense) in the condensed consolidated statements of operations and comprehensive loss.

Sales of future revenues

On November 20, 2020, the Company entered into an agreement with the Canada Strategic Innovation Fund ("SIF"), wherein SIF committed to providing a conditionally repayable loan to the Company in the amount of up to C$40.0 million (the "SIF Loan"). The SIF Loan is conditionally repayable according to a revenue-based formula. See Note 6 - Loans payable, net for additional information concerning the SIF Loan.

The accounting treatment for the SIF Loan considers the "sale of future revenues" guidance promulgated by ASC 470-10-25. The debt arising from the SIF Loan was recorded at face value and will be amortized using the effective interest method, leading to the accrual of interest expenses over the estimated term of the SIF Loan. The amortization schedule is based on projected cash flows derived from the Company's long-term revenue forecast. Subsequent changes in forecasted cash flows will be accounted for under the catch-up method, which entails adjusting the accrued interest portion of the principal balance through earnings to reflect the currently projected effective interest rate. The liability is classified as non-current, as the current forecast indicates that repayments will not commence within the 12 months following the balance sheet date.

As the SIF Loan is originated through a government program, a market rate of interest is not imputed in accordance with the scope limitation provisions of ASC 835.

Fair value of financial instruments

Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:

•Level 1—Quoted prices in active markets for identical assets or liabilities.

•Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.

•Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.

The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company recognizes transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. The Company did not transfer any assets or liabilities in or out of Level 3 during the six months ended June 30, 2025 or 2024.

The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis as of June 30, 2025 and indicates the place in the fair value hierarchy of the valuation inputs the Company utilized to determine each such fair value (in thousands):

Description	Level	As of June 30, 2025
Liabilities:
Warrant Liabilities – Public Warrants	1	$	36,343
Warrant Liabilities – Private Placement Warrants	2	$	54,694

The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss.

For periods subsequent to the detachment of the Public Warrants (as defined below) from the units, the close price of the Public Warrants was used as the fair value of the Warrants as of each relevant date. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units are classified as Level 1 fair value measurements due to the use of an observable market quote in an active market. The subsequent measurements of the Private Warrants after the detachment of the Public Warrants from the Units are classified as Level 2 fair value measurements due to the use of an observable market quote for the Public Warrants, which are considered to be a similar asset in an active market.

Recent accounting pronouncements issued and adopted

None.

Recent accounting pronouncements not yet adopted

Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which requires disaggregated information about our effective tax rate reconciliation as well as information on income taxes paid. The new guidance will first be effective in our annual disclosures for the year ending December 31, 2025, and should be applied on a prospective basis with the option to apply retrospectively. Early adoption is permitted. We are in the process of assessing the impact of ASU 2023-09 on our disclosures.

Expense Disaggregation Disclosures

In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

Climate Disclosures

In March 2024, the SEC adopted new climate disclosure rules requiring public companies to report on material climate-related risks, greenhouse gas emissions (Scopes 1 and 2), climate-related targets, and the financial impacts of severe weather events. However, following multiple legal challenges, the SEC stayed the implementation of these rules in April 2024 pending judicial review.

On March 27, 2025, the SEC announced it would cease defending these climate disclosure rules in court, effectively withdrawing its support for their enforcement.

On April 4, 2025, a group of 18 states and the District of Columbia moved to hold the cases in abeyance until the SEC amends or rescinds the regulations. The motion was granted by the U.S. Court of Appeals for the Eighth Circuit (the "Court") on April 24, 2025. Further, the Court directed the SEC to file a status report by July 23, 2025 to advise the Court whether the SEC intends to review or reconsider the rules at issue in the case. On July 23, 2025, the SEC requested that the Court lift the abeyance imposed on the litigation for the Court to issue a ruling.

While the rules technically remain in place, their future is uncertain as the litigation continues in the Court (Iowa v. SEC, No. 24-1522).

Despite the federal uncertainty, several U.S. states and international jurisdictions have enacted or proposed their own climate disclosure requirements. For instance, California's SB 253 and SB 261 mandate certain companies to disclose greenhouse gas emissions and climate-related financial risks. Additionally, the European Union's Corporate Sustainability Reporting Directive imposes extensive climate-related disclosure obligations on companies operating within its member states.

The Company is actively monitoring these developments and evaluating the potential impact of state and international climate disclosure requirements on its operations and reporting obligations.

XML

REVENUE FROM CONTRACTS WITH CUSTOMERS

6 Months Ended

Jun. 30, 2025

Revenue from Contract with Customer [Abstract]

REVENUE FROM CONTRACTS WITH CUSTOMERS

3. REVENUE FROM CONTRACTS WITH CUSTOMERS

Disaggregation of revenue

Nature of Products and Services

The following table depicts the disaggregation of revenue by type of products or services and timing of transfer of products or services (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Type of products or services
System sales	$	1,025	$	—	$	13,672	$	—
QCaaS	1,241		1,779		2,774		3,471
Professional services	785		342		1,562		1,034
Other revenue*	44		62		88		143
Total revenue	$	3,095	$	2,183	$	18,096	$	4,648
Timing of revenue recognition
Revenue recognized over time	$	3,082	$	2,165	$	5,419	$	4,624
Revenue recognized at a point in time	13		18		12,677		24
Total revenue	$	3,095	$	2,183	$	18,096	$	4,648

*Other revenue includes support and maintenance and printed circuit board sales.

During the three months ended June 30, 2025, the Company recognized revenue of $1.0 million from a system upgrade project, which was classified under system sales.

Geographic Information

The following table presents a summary of revenue by geography for the three and six months ended June 30, 2025 and 2024, based on customer location (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Germany	$	1,186	$	492	$	13,990	$	1,005
United States	710		638		1,207		1,361
Japan	156		124		638		449
Canada	268		350		572		545
Switzerland	331		129		552		304
United Kingdom	62		69		227		197
Other	382		381		911		787
Total revenue	$	3,095	$	2,183	$	18,096	$	4,648

"Other" includes the rest of Europe, the Middle East, the rest of Asia and Australia where the revenue from a single country is not greater than 10% of total consolidated revenue. In accordance with Company policy, the Company has not had any sales in China, Russia or Ukraine.

Significant customers

A significant customer is defined as one that comprises up to ten percent or more of total revenues in a particular year or ten percent of outstanding accounts receivable balance as of the period end.

The tables below present the significant customers on a percentage of total revenue basis for the three and six months ended June 30, 2025 and 2024.

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Customer A	35	%	18	%	76	%	18	%
Customer B	11	%	—	%	—	%	—	%
Customer C	—	%	10	%	—	%	—	%

As of each of June 30, 2025 and 2024, there were five and one significant customers, respectively, that comprised ten percent or more of outstanding accounts receivable balances.

Contract balances

The following table provides information about accounts receivable, contract assets and liabilities as of June 30, 2025 and December 31, 2024 (in thousands):

	As of June 30, 2025		As of December 31, 2024
Trade accounts receivable and contract assets, net:
Trade accounts receivable, net of allowance for doubtful accounts and excluding unbilled receivables	$	820	$	867
Contract asset for unbilled receivables	622		553
Contract acquisition costs	287		174
Total contract assets	$	1,729	$	1,594
Contract liabilities:
Deferred revenue, current	$	4,906	$	18,686
Deferred revenue, non-current	654		670
Customer deposit1	—		48
Total contract liabilities	$	5,560	$	19,404

1Customer deposit is included in accrued expenses and other current liabilities on the condensed consolidated balance sheets.

The allowance for credit losses related to trade accounts receivable was immaterial and $0.2 million as of June 30, 2025 and December 31, 2024. During the three months and six months ended June 30, 2025, the Company recorded $0.1 million write-offs of accounts receivable deemed uncollectible, respectively. During the three months and six months ended June 30, 2024, the Company recorded minimal write-offs of accounts receivable deemed uncollectible.

The revenue recognized in the condensed consolidated statements of operations and comprehensive loss that was included in the contract liability balance at the beginning of each period was $14.6 million and $1.5 million for the six months ended June 30, 2025 and 2024, respectively.

Changes in deferred revenue from contracts with customers were as follows (in thousands):

	Six Months Ended June 30,
	2025		2024
Balance at beginning of period	$	19,356	$	2,748
Deferral of revenue	4,313		4,553
Recognition of deferred revenue	(18,109)		(4,678)
Balance at end of period	$	5,560	$	2,623

Remaining performance obligations

A significant number of the Company’s product and service sales are short-term in nature with a contract term of one year or less. For those contracts, the Company has utilized the practical expedient in ASC 606-10-50-14, exempting the Company from disclosure of the transaction price allocated to remaining performance obligations if the performance obligation is part of a contract that has an original expected duration of one year or less.

As of June 30, 2025, the aggregate amount of remaining performance obligations that were unsatisfied or partially unsatisfied related to customer contracts was $5.3 million, of which approximately 79% is expected to be recognized to revenue in the next 12 months, 91% is expected to be recognized to revenue in the next two years, and 96% is expected to be recognized within three years. Revenues allocated to remaining performance obligations represents the transaction price of noncancellable orders for which service has not been performed, which include deferred revenue and the amounts that will be invoiced and recognized as revenues in future periods from open contracts and excludes unexercised renewals.

XML

BALANCE SHEET DETAILS

6 Months Ended

Jun. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BALANCE SHEET DETAILS

4. BALANCE SHEET DETAILS

Inventories

Inventories consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Raw materials	$	2,446	$	1,677
Work-in-process	2		9
Total inventories	$	2,448	$	1,686

Prepaid expenses and other current assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Prepaid services	$	2,058	$	977
Interest receivable	995		—
Prepaid software	928		845
Prepaid insurance	458		382
Prepaid rent	108		156
Other	791		1,594
Total prepaid expenses and other current assets	$	5,338	$	3,954

Other non-current assets, net

Other non-current assets, net consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Investment in equity securities	$	2,574	$	2,574
Long-term deposits	196		181
Contract acquisition costs, net	287		174
Total	$	3,057	$	2,929

On January 5, 2024, an entity the Company had invested in was acquired by another entity and the transaction was determined to result in an observable price change in the equity security. Consequently, the carrying value of the Company's investment was adjusted based on the consideration received, resulting in a net gain of approximately $1.7 million, recorded in gain on investment in marketable securities on the condensed consolidated statements of operations and comprehensive loss during the six months ended June 30, 2024.

On February 8, 2024, the Company entered into a collaboration arrangement with Zapata to develop and bring to market commercial applications that combine generative AI and quantum computing technologies. As part of the collaboration, the Company purchased the Note with a principal amount of $1.0 million from Zapata. The Note matures on December 15, 2026, and bears interest at 15% per annum. The Note is prepayable without penalty after December 15, 2025 or if the aggregate value of Zapata's convertible notes outstanding falls below $3.0 million. The Note was convertible into Zapata common stock at the Company's option at a conversion price of $8.50, subject to adjustment for stock splits, recapitalizations, and other similar corporate transactions.

On April 1, 2024 the conversion feature associated with the Note was bifurcated from the debt host instrument in connection with the underlying stock becoming readily convertible to cash as the result of a de-SPAC transaction. As a result, the fair value of the conversion feature of $0.2 million was given separate recognition. During the six months ended June 30, 2024, the fair value of the conversion feature was immaterial, resulting in a loss of $0.2 million recorded to gain on investment in marketable securities on the condensed consolidated statements of operations and comprehensive loss.

On October 11, 2024, Zapata announced that it was insolvent and would cease operations. Considering this and other financial information available prior to the balance sheet date as of December 31, 2024, the Note was provisionally determined to be uncollectible, and the Company has recognized a credit loss provision for the entire balance owed of $1.0 million during the year ended December 31, 2024. The charge was recorded within general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss.

The Company was one of two senior-most secured creditors to Zapata. The Note was secured by substantially all of Zapata's assets, including cash accounts, accounts receivables, inventory, contract rights and general intangibles, intellectual property, and equipment, as set forth in the security agreements pertaining to the Note.

Subsequent to the write-off of the Note, in June 2025, the Company recovered the full principal balance of the Note, along with $0.2 million in interest and $0.1 million in legal fees. The recovery was recorded within general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss, offsetting the previously recorded credit loss provision and legal expenses. The cash received for the principal balance of the Note is presented within investing activities in the statement of cash flows. The interest was recorded within Other income, net in the condensed consolidated statements of operations and comprehensive loss.

See Note 2 - Basis of Presentation and Summary of Significant Accounting Policies for additional discussion.

Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Accrued compensation and related benefits	$	7,308	$	5,499
Accrued professional services	1,485		529
Other accruals	2,789		2,756
Total accrued expenses and other current liabilities	$	11,582	$	8,784

XML

PROPERTY AND EQUIPMENT, NET

6 Months Ended

Jun. 30, 2025

Property, Plant and Equipment [Abstract]

PROPERTY AND EQUIPMENT, NET

5. PROPERTY AND EQUIPMENT, NET

Property and equipment, net consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Quantum computer systems	$	13,781	$	14,471
Lab equipment	7,140		6,862
Computer equipment	4,918		4,701
Leasehold improvements	2,213		1,889
Furniture and fixtures	509		381
Construction-in-progress	1,064		836
Total property and equipment	29,625		29,140
Less: Accumulated depreciation	(25,121)		(25,007)
Total property and equipment, net	$	4,504	$	4,133

Depreciation expense for the three months ended June 30, 2025 and 2024 was $0.3 million and $0.2 million, respectively. Depreciation expense for the six months ended June 30, 2025 and 2024 was $0.6 million and $0.4 million, respectively.

XML

LOANS PAYABLE, NET

6 Months Ended

Jun. 30, 2025

Debt Disclosure [Abstract]

LOANS PAYABLE, NET

6. LOANS PAYABLE, NET

As of June 30, 2025 and 2024, loans payable, net, consisted of the SIF Loan, the TPC loan (as defined below) and the Term Loan (as defined below). The following tables show the components of loans payable (in thousands):

	Effective Interest Rate	As of June 30, 2025		As of December 31, 2024
Loans payable, net, current:
TPC Loan, current	Interest free	$	—	$	348
Total loans payable, net, current		$	—	$	348
Loans payable, net, non-current:
SIF Loan	Variable1	$	32,061	$	30,128
Total loans payable, net, non-current		$	32,061	$	30,128

1Refer below for additional information on the SIF Loan repayment period and effective interest rate.

TPC loan

During the period spanning 2010 through 2021, the Company received funding totaling C$12.5 million from Technology Partnerships Canada (the "TPC Loan"). On November 23, 2020, an amendment forgave C$5.0 million of unpaid accrued debt principal and interest from prior years. Additionally, the amendment waived the interest charge on the remaining C$2.5 million of principal and revised the repayment schedule to C$0.5 million due annually on each April 30 through 2025. The TPC loan was fully repaid on April 24, 2025.

SIF Loan

On November 20, 2020, the Company entered into the SIF Loan. As of December 31, 2023, the Company had received the full C$40.0 million in eight tranches between November 2020 and December 2023. Funds from the SIF Loan were used for projects involving the adaptation of research findings for commercial applications that have the potential for market disruption; development of current product and services through the implementation of new or incremental technology that will enhance the Company’s competitive capability; and development of process improvements which reduce the environmental footprint of current production through the use of new or improved technologies.

Principal and interest amounts to be repaid under the SIF Loan are determined using a revenue-based formula, and are capped at 150% of the principal amount (the "Repayment Cap"). Repayments are due in up to 15 annual installments, commencing on April 30 of the second fiscal year following the fiscal year in which the Company first reports annual revenue of at least $70.0 million (the "Benchmark Year"). If the Company fails to reach $70.0 million in annual revenue after 14 years from origination, or if the total of the 15 revenue-based annual installments is less than the principal amount, any remaining repayment obligation will be forgiven.

Repayments of the SIF Loan can also be triggered upon default of the agreement, termination of the agreement, or upon a change of control that has not been approved by the Canadian government. As of June 30, 2025, the Company is not aware of any events that would trigger default or termination of the agreement.

The gross proceeds of the SIF Loan were recorded as a liability related to the sale of future revenues (see Note 2 - Basis of Presentation and Summary of Significant Accounting Policies). As of June 30, 2025 and December 31, 2024, the Company calculated a weighted average effective interest rate for all tranches of 2.46% based on the most recent revenue projections at each reporting date.

The estimated fair value of the SIF Loan (Level 3) at June 30, 2025 was $10.1 million. The fair value of SIF Loan was valued using a discounted cash flow model, with significant assumptions relating to the amount and timing of future revenues and the appropriate discount rate.

Term Loan

On April 13, 2023, the Company entered into the Term Loan with PSPIB Unitas Investments II Inc. ("PSPIB"), a related party to the Company's then largest shareholder. Under the Term Loan, term loans in aggregate principal amount of $50.0 million were to be made available to the Company in three tranches, subject to certain terms and conditions.

The Company fully repaid and extinguished the Term Loan on October 22, 2024, including $30.0 million in principal and $4.3 million in accrued payable in kind ("PIK") interest. The Term Loan, originally set to mature on March 31, 2027, was secured by a first-priority security interest in substantially all of the Company's assets and included certain operational and financial covenants. It bore interest at either 10.0% payable in cash or 11.0% PIK, with the latter added to the principal balance. For the three months ended June 30, 2025 and 2024, the Company recognized zero and $0.9 million, respectively, in interest expense. For the six months ended June 30, 2025 and 2024, the Company recognized zero and $1.8 million, respectively, in interest expense.

Throughout 2023 and 2024, multiple amendments were made to the Term Loan, including covenant waivers, modifications to prepayment requirements, and exemptions for certain share issuance proceeds. The sixth and final amendment, entered on April 16, 2024, provided temporary prepayment exemptions for up to $30.0 million in proceeds from share issuances, with an additional $20.0 million exempt from the 10% prepayment premium.

With the full repayment of the Term Loan, the Company has no remaining obligations under this facility.

XML

WARRANT LIABILITIES

6 Months Ended

Jun. 30, 2025

Other Liabilities Disclosure [Abstract]

WARRANT LIABILITIES

7. WARRANT LIABILITIES

Public and Private Warrants

In conjunction with the Merger, the Company assumed 10,000,000 DPCM public warrants (the "Public Warrants") and 8,000,000 DPCM private warrants (the "Private Warrants"; collectively with the Public Warrants, the "Warrants").

During the six months ended June 30, 2025, 8,636,509 Warrants were exercised by holders in accordance with the Warrant Agreement (as defined below). As a result of these exercises, the Company issued 12,558,471 Common Shares. In connection with the exercises, the Company received cash proceeds of $99.3 million and reclassified $116.9 million, representing the fair value of the warrant liabilities at the time of exercise, from warrant liabilities to additional paid-in capital. The fair value of the liability pertaining to the exercised Warrants was remeasured immediately prior to exercise, and the change in fair value was recognized within change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss.

As of June 30, 2025, the Company has 9,280,047 Warrants outstanding. As part of the Merger, each DPCM Public Warrant and Private Warrant that was issued and outstanding immediately prior to the Merger was automatically and irrevocably converted into one warrant of the Company. The Warrants are subject to the terms and conditions of the warrant agreement entered into between DPCM and Continental Stock Transfer & Trust Company, as amended by an assignment, assumption and amendment agreement with the Company, and further amended to date (as so amended, the “Warrant Agreement”). Effective as of March 11, 2025, Equiniti Trust Company, LLC serves as the warrant agent under the Warrant Agreement.

Each such Warrant is exercisable at an exercise price of $11.50 for 1.4541326 Common Shares, or an approximate exercise price per Common Share of $7.91 (the "Per Share Exercise Price"), subject to adjustments. The Warrants may be exercised for a whole number of Common Shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants will expire on August 5, 2027, or earlier upon redemption or liquidation.

The Private Warrants are identical to the Public Warrants except that, so long as they are held by the initial purchasers or their permitted transferees, the Private Warrants are exercisable by the holders on a cashless basis and are non-redeemable by the Company except as described in the third bullet below. If the Private Warrants are held by holders other than the initial purchasers or their permitted transferees, the Private Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The Company may redeem the outstanding Public Warrants:

•in whole and not in part;

•at $0.01 per Warrant upon a minimum of 30 days' prior written notice of redemption; provided that the last reported sales price of the Common Shares for any twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on which such prior written notice is given (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalization and the like, the "Reference Value") equals or exceeds $18.00 per share;

•alternatively, at $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption; provided that the Reference Value equals or exceeds $10.00 per share, and if the Reference Value is less than $18.00 per share, the outstanding Private Warrants must also be concurrently called for redemption on the same terms as the Public Warrants; and provided further, that the holders may elect to exercise their Warrants on a "cashless basis" prior to redemption and receive a "make-whole exercise" number of Common Shares determined based on the redemption date relative to the remaining period to expiration of the Warrants and the fair market value per Common Share (as described in the Warrant Agreement); and

•if, and only if, there is an effective registration statement covering the issuance of the Common Shares issuable upon exercise of the Warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given, or an exemption from registration is available.

If the Company calls Warrants for redemption as described in either the second or third bullet above, the Company will have the option to require all holders of such Warrants to exercise the Warrants on a “cashless basis,” as described in the Warrant Agreement.

The exercise price and number of Common Shares issuable upon exercise of the Warrants may be adjusted in certain circumstances including in the event of a stock dividend, recapitalization, reorganization, merger or consolidation. However, the Warrants will not be adjusted for issuance of Common Shares at a price below the Per Share Exercise Price. Additionally, in no event will the Company be required to net cash settle the Warrants.

D-Wave Systems Warrant Transaction Agreements

In November 2020, contemporaneously with a revenue arrangement, D-Wave Systems entered into a contract pursuant to which D-Wave Systems agreed to cancel a previously issued warrant with a customer and replace it with a warrant to acquire up to 3,247,637 shares of its Class A Preferred Shares (the “Warrant Preferred Shares”), subject to certain vesting requirements. The warrant agreement was amended on August 5, 2022, contemporaneously with the closing of the Merger, to convert the Warrant Preferred Shares to a warrant to acquire up to 2,889,282 Common Shares of the Company in accordance with the conversion ratio of 0.889657 (the "Conversion Ratio") established in the Merger. The warrants vest based on various contractual milestones. The warrant agreement was terminated on November 28, 2022. As of the termination date of the agreement, approximately 40% of the warrants had vested, resulting in warrants exercisable into 1,155,713 Common Shares remaining after the termination date. The vested warrants will remain exercisable for up to 1,155,713 Common Shares at an exercise price of $2.16 per Common Share until November 29, 2026. As of June 30, 2025, no additional Warrant Preferred Shares were vested and/or were probable of vesting.

XML

STOCK-BASED COMPENSATION

6 Months Ended

Jun. 30, 2025

Share-Based Payment Arrangement [Abstract]

STOCK-BASED COMPENSATION

8. STOCK-BASED COMPENSATION

2020 Equity Incentive Plan

In April 2020, the Board of Directors of D-Wave Systems approved the 2020 Equity Incentive Plan (the "2020 Plan") which provides for the grant of qualified incentive stock options ("ISO") and non-qualified stock options ("NSO"), restricted stock, RSU or other awards to the Company’s employees, officers, directors, advisors, and outside consultants. Following the Merger, awards outstanding under the 2020 Plan continued to be governed by the 2020 Plan; however, the Company will not grant any further awards under the 2020 Plan.

2022 Equity Incentive Plan

On August 5, 2022, the shareholders approved the D-Wave Quantum Inc. 2022 Equity Incentive Plan (the “2022 Plan”), which became effective immediately upon the closing of the Merger. While the 2022 Plan allows for the issuance of awards with a service condition, a performance condition, a market condition, or some combination of the three, to date, the Company has only issued awards subject to a service condition. Awards issued under the 2022 Plan have vesting periods ranging from under 1 year to 4 years from the original grant date, and all awards issued to date under the 2022 Plan will expire 10 years from the original grant date.

Share-based compensation awards are settled by issuing new shares.

Common stock option activity

The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data):

	Number of options	Weighted  average  exercise price  ($)	Weighted average remaining contractual term (years)	Aggregate intrinsic value ($)
Outstanding as of December 31, 2024	10,984,738	1.67	6.64	75,270
Granted	—	—
Exercised	(4,202,187)	1.65
Forfeited and expired	(6,118)	4.73
Outstanding as of June 30, 2025	6,776,433	1.67	6.31	87,857
Options exercisable as of June 30, 2025	5,652,479	1.48	5.91	74,408
Options unvested as of June 30, 2025	1,123,954	2.67	8.33	13,449

During the six months ended June 30, 2025 and 2024, the total intrinsic value of options exercised was $63.5 million and immaterial, respectively.

Restricted stock unit awards

The following table summarizes the restricted stock unit ("RSU") activity and related information under the 2022 Plan:

	Number of RSUs	Weighted average Grant Date Fair Value ($)
Unvested as of December 31, 2024	8,787,022	2.25
Granted	4,773,987	9.28
Forfeited and expired	(166,418)	4.88
Vested	(2,499,947)	2.47
Unvested as of June 30, 2025	10,894,644	5.24

Employee Stock Purchase Plan

During the six months ended June 30, 2025, 95,331 Common Shares were issued under the Employee Stock Purchase Plan (the "ESPP"), and compensation cost recognized related to the ESPP was $0.2 million.

Stock-based compensation expense

The following table summarizes the stock-based compensation expense classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Cost of revenue	$	231	$	154	$	373	$	329
Research and development	2,329		1,311		3,783		2,432
General and administrative	3,083		2,248		4,900		4,206
Sales and marketing	1,028		508		1,608		763
Total stock-based compensation	$	6,671	$	4,221	$	10,664	$	7,730

During the three months ended June 30, 2025 and 2024, total compensation cost capitalized as part of property and equipment and intangible assets was $0.1 million and zero, respectively. During the six months ended June 30, 2025 and 2024, total compensation cost capitalized as part of property and equipment and intangible assets was $0.1 million and zero, respectively.

As of June 30, 2025, total unrecognized stock-based compensation cost, net of estimated forfeitures, related to our unvested stock awards was $52.5 million. This amount is based on an estimated future forfeiture rate of 2.34% per year and will be recognized over a weighted-average period of approximately 3.41 years.

XML

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Jun. 30, 2025

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

9. COMMITMENTS AND CONTINGENCIES

Lease obligations

The Company primarily enters into leases for office space that are classified as operating leases. During the three months ended June 30, 2025 and 2024, total operating lease costs were $0.5 million and $0.6 million, respectively. Total operating lease costs were $1.0 million for each of the six months ended June 30, 2025 and 2024.

Litigation

From time to time, the Company may become involved in various legal proceedings in the ordinary course of its business and may be subject to third-party infringement claims.

In the normal course of business, the Company may agree to indemnify third parties with whom it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company, with respect to certain matters. The Company has agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that the Company’s products, when used for their intended purposes, infringe the intellectual property rights of such other third parties, or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim.

As of June 30, 2025, the Company was not subject to any material litigation or pending litigation claims.

XML

NET LOSS PER SHARE

6 Months Ended

Jun. 30, 2025

Earnings Per Share [Abstract]

NET LOSS PER SHARE

10. NET LOSS PER SHARE

The following tables set forth the computation of the basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2025 and 2024 (in thousands, except share and per share data):

	Three Months Ended June 30,
	2025		2024
Numerator:
Net loss attributable to common stockholders - basic and diluted	$	(167,329)	$	(17,778)
Denominator:
Weighted-average common stock outstanding	302,288,793		172,139,085
Net loss per share attributable to common stockholders - basic and diluted	$	(0.55)	$	(0.10)

	Six Months Ended June 30,
	2025		2024
Numerator:
Net loss attributable to common stockholders - basic and diluted	$	(172,750)	$	(35,090)
Denominator:
Weighted-average common stock outstanding	294,398,419		166,723,787
Net loss per share attributable to common stockholders - basic and diluted	$	(0.59)	$	(0.21)

Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential Common Shares outstanding would have been anti-dilutive.

Potentially dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:

	Six Months Ended June 30,
	2025	2024
Public Warrants as converted to Common Shares (Note 7)	5,387,118	14,420,065
Private Warrants as converted to Common Shares (Note 7)	8,107,302	11,633,060
D-Wave Systems Warrant Preferred Shares as converted to Common Shares (Note 7)	1,155,713	1,155,713
Stock options issued and outstanding	6,776,433	12,966,583
Unvested restricted stock unit awards	10,894,644	10,237,298
Total	32,321,210	50,412,719

XML

SEGMENT AND GEOGRAPHIC INFORMATION

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

SEGMENT AND GEOGRAPHIC INFORMATION

11. SEGMENT AND GEOGRAPHIC INFORMATION

The Company operates as one operating segment managed on a consolidated basis. The financial information regularly reviewed by the Chief Operating Decision Maker ("CODM") is presented on the same basis as the Company's consolidated financial statements. The measure of profit or loss used by the CODM to allocate resources and assess performance is consolidated net loss. Significant expense categories are not presented, as the expense information regularly provided to the CODM is presented on the same basis as the consolidated statements of operations and comprehensive loss. The CODM relies on consolidated net loss as a comprehensive measure of the Company, considering all revenues and expenses, including cost of revenue, research and development expenses, general and administrative expenses and sales and marketing expenses, to assess the Company’s overall performance and inform strategic decisions on cost control, pricing and investments. Additionally, the CODM also reviews total assets to assess the Company's financial position and resource allocation. The CODM also reviews forward-looking expense information contained in budgets and operating plans to manage operations and allocate resources.

See the condensed consolidated financial statements and accompanying footnotes for consolidated net loss, total expenditures for additions to long-lived assets, total assets and other financial information regarding the Company’s single operating segment. See Note 3 - Revenue from contracts with customers for additional information about revenue by geography.

The following table sets forth the long-lived assets, consisting of property and plant, net, and operating lease right-of-use assets, by geographic area as follows (in thousands):

	As of June 30, 2025		As of December 31, 2024
Canada	$	10,883	$	11,005
United States	470		381
Other	66		8
Total long-lived assets	$	11,419	$	11,394

XML

SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2025

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

12. SUBSEQUENT EVENTS

The Company has evaluated all events occurring through August 7, 2025, the date on which the condensed consolidated financial statements were issued, and during which time, nothing has occurred outside the normal course of business operations that would require disclosure except the following:

Lease Agreement

On July 1, 2025, we entered into an operating lease commitment related to one mixed-use office and industrial property adjacent to our Burnaby, BC facility. The lease is expected to commence in the first quarter of 2026. Upon commencement, we expect to recognize aggregate right‑of‑use assets and lease liabilities of approximately $1.0 million.

Warrant Exercises

Subsequent to the end of the quarter, 1,308,658 Warrants were exercised by holders in accordance with the Warrant Agreement. As a result of these exercises, the Company issued 1,902,962 Common Shares. In connection with the exercises, the Company received cash proceeds of $15.0 million.

Equipment Financing Agreement

On August 1, 2025, we entered into an equipment financing agreement. The agreement provides for a total conditional commitment of $13.8 million, with an initial draw of $0.5 million made at execution. The remaining commitment is available until February 1, 2027, which may be extended to August 1, 2027 if at least $11.5 million is drawn by that date. A commitment fee of 1% of the conditional commitment is payable upon the initial draw, and the lender will receive a ten-year warrant to purchase 21,563 Common Shares at an exercise price of $16.05 per share. A non-utilization fee of 3% will apply to the undrawn portion of the first $11.5 million as of the termination date (defined as either February 1, 2027 or August 1, 2027, as applicable).

We will execute one or more equipment financing schedules to evidence each draw. The interest rate for each schedule is based on a spread of approximately 2.2% over the Prime Rate (which was 7.5% at the time of signing) and are fixed at the rate applicable to each respective schedule. However, the rate will not fall below the rate of the initial schedule, which is 9.7%. The lender will hold a first-priority security interest in all financed equipment.

XML

Insider Trading Arrangements

3 Months Ended

Jun. 30, 2025

shares

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

During the three months ended June 30, 2025, the following directors of the Company each adopted a "Rule 10b5-1 trading arrangement", as such term is defined under Item 408 of Regulation S-K:

Name of Director	Date of Adoption	Expiration Date of Trading Arrangement1	Aggregate Number of Securities to be Sold
Rohit Ghai	June 13, 2025	June 30, 2026	Up to 43,518 shares of common stock issuable upon vesting of restricted stock units
John DiLullo	June 15, 2025	December 31, 2026	Up to 34,050 shares of common stock issuable upon vesting of restricted stock units

1 The trading arrangement may end earlier if all transactions under the trading arrangement are completed prior to the expiration date.

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Rohit Ghai [Member]

Trading Arrangements, by Individual

Name

Rohit Ghai

Title

director

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

June 13, 2025

Expiration Date

June 30, 2026

Arrangement Duration

382 days

Aggregate Available

43,518

John DiLullo [Member]

Trading Arrangements, by Individual

Name

John DiLullo

Title

director

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

June 15, 2025

Expiration Date

December 31, 2026

Arrangement Duration

564 days

Aggregate Available

34,050

XML

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Jun. 30, 2025

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The unaudited interim condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosure normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the United States Securities and Exchange Commission ("SEC"). In the opinion of the Company, the unaudited financial information for the interim periods presented reflects all adjustments, which are normal and recurring, necessary for a fair presentation of the condensed consolidated balance sheets, condensed consolidated statements of operations and comprehensive loss, and condensed consolidated statements of cash flows. Interim results should not be regarded as indicative of results that may be expected for any other period or the entire year.

The interim condensed consolidated financial statements included herein have been prepared on the same basis as the audited annual consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K as of and for the year ended December 31, 2024 filed with the SEC on March 14, 2025.

Principles of Consolidation

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in the condensed consolidated financial statements upon consolidation.

Use of estimates

Use of estimates

The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. The most significant estimates and assumptions are used in determining: (i) inputs used to recognize revenue over time relating to hours estimated to complete the remaining performance obligations, (ii) fair value of financial instruments, and (iii) long term revenue forecasts used in the accounting for the SIF Loan (see below and Note 6 for further information). These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.

The Company’s accounting estimates and assumptions may change over time in response to risks and uncertainties, including uncertainty in the current economic environment due to inflation, tariffs, changes in interest rates and monetary policy, various geopolitical conflicts, and any evolutions thereof. The change could be material in future periods. As of the date of issuance of these condensed consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.

Investment in securities

Investment in securities

The Company holds investments in the equity securities of privately held companies, which are valued based on their original cost. Adjustments are made for observable price changes in orderly transactions involving identical or similar securities of the same issuer, as there are no quoted market prices available.

Sales of future revenues

Sales of future revenues

On November 20, 2020, the Company entered into an agreement with the Canada Strategic Innovation Fund ("SIF"), wherein SIF committed to providing a conditionally repayable loan to the Company in the amount of up to C$40.0 million (the "SIF Loan"). The SIF Loan is conditionally repayable according to a revenue-based formula. See Note 6 - Loans payable, net for additional information concerning the SIF Loan.

The accounting treatment for the SIF Loan considers the "sale of future revenues" guidance promulgated by ASC 470-10-25. The debt arising from the SIF Loan was recorded at face value and will be amortized using the effective interest method, leading to the accrual of interest expenses over the estimated term of the SIF Loan. The amortization schedule is based on projected cash flows derived from the Company's long-term revenue forecast. Subsequent changes in forecasted cash flows will be accounted for under the catch-up method, which entails adjusting the accrued interest portion of the principal balance through earnings to reflect the currently projected effective interest rate. The liability is classified as non-current, as the current forecast indicates that repayments will not commence within the 12 months following the balance sheet date.

As the SIF Loan is originated through a government program, a market rate of interest is not imputed in accordance with the scope limitation provisions of ASC 835.

Fair value of financial instruments

Fair value of financial instruments

Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:

•Level 1—Quoted prices in active markets for identical assets or liabilities.

•Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.

•Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.

The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company recognizes transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. The Company did not transfer any assets or liabilities in or out of Level 3 during the six months ended June 30, 2025 or 2024.

The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss.

For periods subsequent to the detachment of the Public Warrants (as defined below) from the units, the close price of the Public Warrants was used as the fair value of the Warrants as of each relevant date. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units are classified as Level 1 fair value measurements due to the use of an observable market quote in an active market. The subsequent measurements of the Private Warrants after the detachment of the Public Warrants from the Units are classified as Level 2 fair value measurements due to the use of an observable market quote for the Public Warrants, which are considered to be a similar asset in an active market.

Recent accounting pronouncements issued and adopted

Recent accounting pronouncements issued and adopted

None.

Recent accounting pronouncements not yet adopted

Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which requires disaggregated information about our effective tax rate reconciliation as well as information on income taxes paid. The new guidance will first be effective in our annual disclosures for the year ending December 31, 2025, and should be applied on a prospective basis with the option to apply retrospectively. Early adoption is permitted. We are in the process of assessing the impact of ASU 2023-09 on our disclosures.

Expense Disaggregation Disclosures

In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

Climate Disclosures

In March 2024, the SEC adopted new climate disclosure rules requiring public companies to report on material climate-related risks, greenhouse gas emissions (Scopes 1 and 2), climate-related targets, and the financial impacts of severe weather events. However, following multiple legal challenges, the SEC stayed the implementation of these rules in April 2024 pending judicial review.

On March 27, 2025, the SEC announced it would cease defending these climate disclosure rules in court, effectively withdrawing its support for their enforcement.

On April 4, 2025, a group of 18 states and the District of Columbia moved to hold the cases in abeyance until the SEC amends or rescinds the regulations. The motion was granted by the U.S. Court of Appeals for the Eighth Circuit (the "Court") on April 24, 2025. Further, the Court directed the SEC to file a status report by July 23, 2025 to advise the Court whether the SEC intends to review or reconsider the rules at issue in the case. On July 23, 2025, the SEC requested that the Court lift the abeyance imposed on the litigation for the Court to issue a ruling.

While the rules technically remain in place, their future is uncertain as the litigation continues in the Court (Iowa v. SEC, No. 24-1522).

Despite the federal uncertainty, several U.S. states and international jurisdictions have enacted or proposed their own climate disclosure requirements. For instance, California's SB 253 and SB 261 mandate certain companies to disclose greenhouse gas emissions and climate-related financial risks. Additionally, the European Union's Corporate Sustainability Reporting Directive imposes extensive climate-related disclosure obligations on companies operating within its member states.

The Company is actively monitoring these developments and evaluating the potential impact of state and international climate disclosure requirements on its operations and reporting obligations.

XML

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2025

Accounting Policies [Abstract]

Schedule of Liabilities Measured at Fair Value on a Recurring Basis

The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis as of June 30, 2025 and indicates the place in the fair value hierarchy of the valuation inputs the Company utilized to determine each such fair value (in thousands):

Description	Level	As of June 30, 2025
Liabilities:
Warrant Liabilities – Public Warrants	1	$	36,343
Warrant Liabilities – Private Placement Warrants	2	$	54,694

XML

REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables)

6 Months Ended

Jun. 30, 2025

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table depicts the disaggregation of revenue by type of products or services and timing of transfer of products or services (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Type of products or services
System sales	$	1,025	$	—	$	13,672	$	—
QCaaS	1,241		1,779		2,774		3,471
Professional services	785		342		1,562		1,034
Other revenue*	44		62		88		143
Total revenue	$	3,095	$	2,183	$	18,096	$	4,648
Timing of revenue recognition
Revenue recognized over time	$	3,082	$	2,165	$	5,419	$	4,624
Revenue recognized at a point in time	13		18		12,677		24
Total revenue	$	3,095	$	2,183	$	18,096	$	4,648

*Other revenue includes support and maintenance and printed circuit board sales.

The following table presents a summary of revenue by geography for the three and six months ended June 30, 2025 and 2024, based on customer location (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Germany	$	1,186	$	492	$	13,990	$	1,005
United States	710		638		1,207		1,361
Japan	156		124		638		449
Canada	268		350		572		545
Switzerland	331		129		552		304
United Kingdom	62		69		227		197
Other	382		381		911		787
Total revenue	$	3,095	$	2,183	$	18,096	$	4,648

Schedule of Significant Customers

The tables below present the significant customers on a percentage of total revenue basis for the three and six months ended June 30, 2025 and 2024.

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Customer A	35	%	18	%	76	%	18	%
Customer B	11	%	—	%	—	%	—	%
Customer C	—	%	10	%	—	%	—	%

Schedule of Contract Balances and Revenue Recognized

The following table provides information about accounts receivable, contract assets and liabilities as of June 30, 2025 and December 31, 2024 (in thousands):

	As of June 30, 2025		As of December 31, 2024
Trade accounts receivable and contract assets, net:
Trade accounts receivable, net of allowance for doubtful accounts and excluding unbilled receivables	$	820	$	867
Contract asset for unbilled receivables	622		553
Contract acquisition costs	287		174
Total contract assets	$	1,729	$	1,594
Contract liabilities:
Deferred revenue, current	$	4,906	$	18,686
Deferred revenue, non-current	654		670
Customer deposit1	—		48
Total contract liabilities	$	5,560	$	19,404

1Customer deposit is included in accrued expenses and other current liabilities on the condensed consolidated balance sheets.

Changes in deferred revenue from contracts with customers were as follows (in thousands):

	Six Months Ended June 30,
	2025		2024
Balance at beginning of period	$	19,356	$	2,748
Deferral of revenue	4,313		4,553
Recognition of deferred revenue	(18,109)		(4,678)
Balance at end of period	$	5,560	$	2,623

XML

BALANCE SHEET DETAILS (Tables)

6 Months Ended

Jun. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Inventories

Inventories consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Raw materials	$	2,446	$	1,677
Work-in-process	2		9
Total inventories	$	2,448	$	1,686

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Prepaid services	$	2,058	$	977
Interest receivable	995		—
Prepaid software	928		845
Prepaid insurance	458		382
Prepaid rent	108		156
Other	791		1,594
Total prepaid expenses and other current assets	$	5,338	$	3,954

Schedule of Other Noncurrent Assets

Other non-current assets, net consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Investment in equity securities	$	2,574	$	2,574
Long-term deposits	196		181
Contract acquisition costs, net	287		174
Total	$	3,057	$	2,929

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Accrued compensation and related benefits	$	7,308	$	5,499
Accrued professional services	1,485		529
Other accruals	2,789		2,756
Total accrued expenses and other current liabilities	$	11,582	$	8,784

XML

PROPERTY AND EQUIPMENT, NET (Tables)

6 Months Ended

Jun. 30, 2025

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

	As of June 30, 2025		As of December 31, 2024
Quantum computer systems	$	13,781	$	14,471
Lab equipment	7,140		6,862
Computer equipment	4,918		4,701
Leasehold improvements	2,213		1,889
Furniture and fixtures	509		381
Construction-in-progress	1,064		836
Total property and equipment	29,625		29,140
Less: Accumulated depreciation	(25,121)		(25,007)
Total property and equipment, net	$	4,504	$	4,133

XML

LOANS PAYABLE, NET (Tables)

6 Months Ended

Jun. 30, 2025

Debt Disclosure [Abstract]

Schedule of Components of Loans Payable

The following tables show the components of loans payable (in thousands):

	Effective Interest Rate	As of June 30, 2025		As of December 31, 2024
Loans payable, net, current:
TPC Loan, current	Interest free	$	—	$	348
Total loans payable, net, current		$	—	$	348
Loans payable, net, non-current:
SIF Loan	Variable1	$	32,061	$	30,128
Total loans payable, net, non-current		$	32,061	$	30,128

1Refer below for additional information on the SIF Loan repayment period and effective interest rate.

XML

STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data):

	Number of options	Weighted  average  exercise price  ($)	Weighted average remaining contractual term (years)	Aggregate intrinsic value ($)
Outstanding as of December 31, 2024	10,984,738	1.67	6.64	75,270
Granted	—	—
Exercised	(4,202,187)	1.65
Forfeited and expired	(6,118)	4.73
Outstanding as of June 30, 2025	6,776,433	1.67	6.31	87,857
Options exercisable as of June 30, 2025	5,652,479	1.48	5.91	74,408
Options unvested as of June 30, 2025	1,123,954	2.67	8.33	13,449

Schedule of RSU Activity and Related Information

The following table summarizes the restricted stock unit ("RSU") activity and related information under the 2022 Plan:

	Number of RSUs	Weighted average Grant Date Fair Value ($)
Unvested as of December 31, 2024	8,787,022	2.25
Granted	4,773,987	9.28
Forfeited and expired	(166,418)	4.88
Vested	(2,499,947)	2.47
Unvested as of June 30, 2025	10,894,644	5.24

Schedule of Stock-Based Compensation Expense

The following table summarizes the stock-based compensation expense classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Cost of revenue	$	231	$	154	$	373	$	329
Research and development	2,329		1,311		3,783		2,432
General and administrative	3,083		2,248		4,900		4,206
Sales and marketing	1,028		508		1,608		763
Total stock-based compensation	$	6,671	$	4,221	$	10,664	$	7,730

XML

NET LOSS PER SHARE (Tables)

6 Months Ended

Jun. 30, 2025

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Loss Per Share

The following tables set forth the computation of the basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2025 and 2024 (in thousands, except share and per share data):

	Three Months Ended June 30,
	2025		2024
Numerator:
Net loss attributable to common stockholders - basic and diluted	$	(167,329)	$	(17,778)
Denominator:
Weighted-average common stock outstanding	302,288,793		172,139,085
Net loss per share attributable to common stockholders - basic and diluted	$	(0.55)	$	(0.10)

	Six Months Ended June 30,
	2025		2024
Numerator:
Net loss attributable to common stockholders - basic and diluted	$	(172,750)	$	(35,090)
Denominator:
Weighted-average common stock outstanding	294,398,419		166,723,787
Net loss per share attributable to common stockholders - basic and diluted	$	(0.59)	$	(0.21)

Schedule of Potentially Dilutive Securities

Potentially dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:

	Six Months Ended June 30,
	2025	2024
Public Warrants as converted to Common Shares (Note 7)	5,387,118	14,420,065
Private Warrants as converted to Common Shares (Note 7)	8,107,302	11,633,060
D-Wave Systems Warrant Preferred Shares as converted to Common Shares (Note 7)	1,155,713	1,155,713
Stock options issued and outstanding	6,776,433	12,966,583
Unvested restricted stock unit awards	10,894,644	10,237,298
Total	32,321,210	50,412,719

XML

SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Schedule of Long-lived assets by geographic area

The following table sets forth the long-lived assets, consisting of property and plant, net, and operating lease right-of-use assets, by geographic area as follows (in thousands):

	As of June 30, 2025		As of December 31, 2024
Canada	$	10,883	$	11,005
United States	470		381
Other	66		8
Total long-lived assets	$	11,419	$	11,394

XML

DESCRIPTION OF BUSINESS (Details)	Jun. 30, 2025 facility
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which entity operates	3

XML

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)		6 Months Ended	12 Months Ended
	Dec. 31, 2024 USD ($)	Jun. 30, 2025 USD ($) shares	Dec. 31, 2024 USD ($)	Dec. 31, 2023 CAD ($)	Nov. 20, 2020 CAD ($)
Accounting Policies [Line Items]
Revenues		$ 1,000,000.0
Credit loss	$ 1,000,000		$ 1,000,000.0
Warrants exercised (in shares) | shares		8,636,509
Class of warrant or right, number of common stock shares issued (in shares) | shares		12,558,471
Financing Receivable, Accrued Interest, Recovery		$ 200,000
Financing Receivable, Legal Fees Recovered		100,000
Allowance for credit losses	$ (200,000)	$ 0	$ (200,000)
SIF Loan
Accounting Policies [Line Items]
Face amount				$ 40,000,000.0	$ 40,000,000.0

XML

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Liabilities:
Warrants	$ 91,037	$ 69,875
Fair Value, Inputs, Level 1 | Public Warrants
Liabilities:
Warrants	36,343
Fair Value, Inputs, Level 2 | Private Warrants
Liabilities:
Warrants	$ 54,694

XML

REVENUE FROM CONTRACTS WITH CUSTOMERS - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Disaggregation of Revenue [Line Items]
Total revenue	$ 3,095	$ 2,183	$ 18,096	$ 4,648
Germany
Disaggregation of Revenue [Line Items]
Total revenue	1,186	492	13,990	1,005
United States
Disaggregation of Revenue [Line Items]
Total revenue	710	638	1,207	1,361
Japan
Disaggregation of Revenue [Line Items]
Total revenue	156	124	638	449
Canada
Disaggregation of Revenue [Line Items]
Total revenue	268	350	572	545
Switzerland
Disaggregation of Revenue [Line Items]
Total revenue	331	129	552	304
United Kingdom
Disaggregation of Revenue [Line Items]
Total revenue	62	69	227	197
Other
Disaggregation of Revenue [Line Items]
Total revenue	382	381	911	787
Revenue recognized over time
Disaggregation of Revenue [Line Items]
Total revenue	3,082	2,165	5,419	4,624
Revenue recognized at a point in time
Disaggregation of Revenue [Line Items]
Total revenue	13	18	12,677	24
System sales
Disaggregation of Revenue [Line Items]
Total revenue	1,025	0	13,672	0
QCaaS
Disaggregation of Revenue [Line Items]
Total revenue	1,241	1,779	2,774	3,471
Professional services
Disaggregation of Revenue [Line Items]
Total revenue	785	342	1,562	1,034
Other revenue
Disaggregation of Revenue [Line Items]
Total revenue	$ 44	$ 62	$ 88	$ 143

XML

REVENUE FROM CONTRACTS WITH CUSTOMERS - Narrative (Details)	6 Months Ended
	Jun. 30, 2025 USD ($) customer	Jun. 30, 2024 USD ($) customer	Dec. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenues	$ 1,000,000.0
Number of customers | customer	5	1
Allowance for credit losses	$ 0		$ 200,000
Restructuring and related cost, expected cost	100,000
Revenue recognized	14,600,000	$ 1,500,000
Remaining performance obligation	$ 5,300,000
Remaining performance obligation, percentage to be recognized in next 12 months	79.00%
Remaining performance obligation, percentage to be recognized in next two years	91.00%
Revenue, remaining performance obligation, percentage to be recognized in years one, two and three	96.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, period	3 years
Two Customers | Accounts receivable | Customer concentration risk
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Concentration risk, percentage	10.00%	10.00%
Three Customers | Accounts receivable | Customer concentration risk
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Concentration risk, percentage	10.00%	10.00%

XML

REVENUE FROM CONTRACTS WITH CUSTOMERS - Significant Customers (Details) - Revenue benchmark - Customer concentration risk	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Customer A
Concentration Risk [Line Items]
Concentration risk, percentage	35.00%	18.00%	76.00%	18.00%
Customer B
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%	0.00%	0.00%	0.00%
Customer C
Concentration Risk [Line Items]
Concentration risk, percentage	0.00%	10.00%	0.00%	0.00%

XML

REVENUE FROM CONTRACTS WITH CUSTOMERS - Receivables, Contract Assets and Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Trade accounts receivable and contract assets, net:
Trade accounts receivable, net of allowance for doubtful accounts and excluding unbilled receivables	$ 820	$ 867
Contract asset for unbilled receivables	622	553
Contract acquisition costs	287	174
Total contract assets	1,729	1,594
Contract liabilities:
Deferred revenue, current	4,906	18,686
Deferred revenue, non-current	654	670
Customer deposit	0	48
Total contract liabilities	$ 5,560	$ 19,404

XML

REVENUE FROM CONTRACTS WITH CUSTOMERS - Change in Deferred Revenue (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Contract With Customer, Liability [Roll Forward]
Balance at beginning of period	$ 19,356	$ 2,748
Deferral of revenue	4,313	4,553
Recognition of deferred revenue	(18,109)	(4,678)
Balance at end of period	$ 5,560	$ 2,623

XML

BALANCE SHEET DETAILS - Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 2,446	$ 1,677
Work-in-process	2	9
Total inventories	$ 2,448	$ 1,686

XML

BALANCE SHEET DETAILS - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid services	$ 2,058	$ 977
Interest receivable	995	0
Prepaid software	928	845
Prepaid insurance	458	382
Prepaid rent	108	156
Other	791	1,594
Total prepaid expenses and other current assets	$ 5,338	$ 3,954

XML

BALANCE SHEET DETAILS - Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Investment in equity securities	$ 2,574	$ 2,574
Long-term deposits	196	181
Contract acquisition costs, net	287	174
Total	$ 3,057	$ 2,929

XML

BALANCE SHEET DETAILS - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2024	Jan. 05, 2024	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024	Apr. 01, 2024	Feb. 08, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Gain (Loss) on Investments		$ 1,700	$ 0	$ (157)	$ 0	$ 1,503
Note receivable, principal amount									$ 1,000
Note receivable, interest rate									15.00%
Note receivable, prepayable without penalty, aggregate value, maximum									$ 3,000
Note receivable, conversion price (in usd per share)									$ 8.50
Fair value conversion feature	$ 0						$ 0	$ 200
Marketable securities	200						200
Credit loss	$ 1,000						$ 1,000

XML

BALANCE SHEET DETAILS - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued compensation and related benefits	$ 7,308	$ 5,499
Accrued professional services	1,485	529
Other accruals	2,789	2,756
Total accrued expenses and other current liabilities	$ 11,582	$ 8,784

XML

PROPERTY AND EQUIPMENT, NET (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 29,625		$ 29,625		$ 29,140
Less: Accumulated depreciation	(25,121)		(25,121)		(25,007)
Total property and equipment, net	4,504		4,504		4,133
Depreciation expense	300	$ 200	600	$ 400
Quantum computer systems
Property, Plant and Equipment [Line Items]
Total property and equipment	13,781		13,781		14,471
Lab equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	7,140		7,140		6,862
Computer equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	4,918		4,918		4,701
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	2,213		2,213		1,889
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	509		509		381
Construction-in-progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 1,064		$ 1,064		$ 836

XML

LOANS PAYABLE, NET - Components of Loans Payable (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Debt Instrument [Line Items]
Total loans payable, net, current	$ 0	$ 348
Total loans payable, net, non-current	32,061	30,128
TPC Loan, current | Other notes payable
Debt Instrument [Line Items]
Total loans payable, net, current	0	348
SIF Loan | Other notes payable
Debt Instrument [Line Items]
Total loans payable, net, non-current	$ 32,061	$ 30,128

XML

LOANS PAYABLE, NET - Narrative (Details)				3 Months Ended		6 Months Ended		144 Months Ended
	Oct. 22, 2024 USD ($)	Apr. 16, 2024 USD ($)	Nov. 20, 2020 USD ($) installment	Jun. 30, 2025 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2025 USD ($)	Jun. 30, 2024 USD ($)	Dec. 31, 2021 CAD ($)	Dec. 31, 2024	Dec. 31, 2023 CAD ($) tranche	Apr. 13, 2023 USD ($) tranche	Nov. 23, 2020 CAD ($)	Nov. 20, 2020 CAD ($)
Debt Instrument [Line Items]
Debt instrument, repaid, principal	$ 30,000,000
Interest payments	$ 4,300,000
Interest expense, other				$ 206,000	$ 1,160,000	$ 432,000	$ 2,300,000
TPC Loan, current | Other notes payable
Debt Instrument [Line Items]
Proceeds from loan								$ 12,500,000
Debt forgiven												$ 5,000,000
Debt forgiveness, interest waived principal												2,500,000
Annual principal payment												$ 500,000
SIF Loan
Debt Instrument [Line Items]
Face amount										$ 40,000,000.0			$ 40,000,000.0
Debt, number of tranches | tranche										8
Repayment rate			150.00%										150.00%
Repayment, number of installments | installment			15
Repayment benchmark year, revenue			$ 70,000,000.0
Repayment benchmark year, period			14 years										14 years
Weighted average effective interest rate				2.46%		2.46%			2.46%
SIF Loan | Fair Value, Inputs, Level 2
Debt Instrument [Line Items]
Loans, fair value				$ 10,100,000		$ 10,100,000
Term Loan | Line of credit
Debt Instrument [Line Items]
Face amount											$ 50,000,000
Debt, number of tranches | tranche											3
Interest rate											10.00%
Debt, interest rate, payable in kind											11.00%
Interest expense, other				$ 0	$ 900,000	$ 0	$ 1,800,000
Proceeds from issuance of common stock		$ 30,000,000.0
Additional proceeds from issuance of common stock		$ 20,000,000.0
Debt, premium payment, percentage of amount prepaid		10.00%

XML

WARRANT LIABILITIES (Details)		6 Months Ended
	Aug. 05, 2022 $ / shares shares	Jun. 30, 2025 USD ($) day $ / shares shares	Jun. 30, 2024 USD ($)	Nov. 28, 2022	Nov. 30, 2020 shares
Class of Warrant or Right [Line Items]
Warrants exercised (in shares) | shares		8,636,509
Class of warrant or right, number of common stock shares issued (in shares) | shares		12,558,471
Proceeds from issuance of common stock upon exercise of warrants | $		$ 99,319,000	$ 0
Reclassification of warrant liability to equity upon exercise | $		$ 116,943,000	$ 0
Warrants outstanding (in shares) | shares		9,280,047
Number of warrants into which each warrant was converted (in shares) | shares		1
Warrants, exercise price, prior to exchange ratio (in usd per share) | $ / shares		$ 11.50
Exchange ratio		1.4541326
Warrants, exercise price (in usd per share) | $ / shares		$ 7.91
Warrants, redemption notice period		30 days
Warrants, number of shares issuable (in shares) | shares		1,155,713
Conversion ratio	0.889657
Class Of Warrant Or Right, Redemption Option One
Class of Warrant or Right [Line Items]
Warrants, redemption price (in usd per share) | $ / shares		$ 0.01
Warrants, redemption notice period		30 days
Warrants, redemption share price threshold trading days | day		20
Warrants, redemption share price threshold consecutive trading days		30 days
Sale of stock, price (in usd per share) | $ / shares		$ 18.00
Class Of Warrant Or Right, Redemption Option Two
Class of Warrant or Right [Line Items]
Warrants, redemption price (in usd per share) | $ / shares		$ 0.10
Warrants, redemption notice period		30 days
Sale of stock, price (in usd per share) | $ / shares	$ 10.00
Reference value (in usd per share) | $ / shares		$ 18.00
Public Warrants
Class of Warrant or Right [Line Items]
Merger, warrants assumed (in shares) | shares	10,000,000
Private Warrants
Class of Warrant or Right [Line Items]
Merger, warrants assumed (in shares) | shares	8,000,000
Preferred stock warrants
Class of Warrant or Right [Line Items]
Warrants, exercise price (in usd per share) | $ / shares		$ 2.16
Warrants, number of shares issuable (in shares) | shares	2,889,282				3,247,637
Warrants vested, percentage				40.00%
Warrants vested, fair value | $		$ 0

XML

STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)		3 Months Ended		6 Months Ended
	Aug. 05, 2022	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expiration period (in years)	10 years
Share-based payment award, options, exercises in period, intrinsic value				$ 63,500,000	$ 0
Total stock-based compensation		$ 6,671,000	$ 4,221,000	10,664,000	7,730,000
Capitalized stock-based compensation		100,000	$ 0	132,000	$ 0
Unrecognized compensation cost related to unvested stock awards		$ 52,500,000		$ 52,500,000
Future forfeiture rate (as a percent)				2.34%
Period for recognition of compensation cost (in years)				3 years 4 months 28 days
ESPP
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation				$ 200,000
Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period (in years)	1 year
Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period (in years)	4 years

XML

STOCK-BASED COMPENSATION - Stock Options Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2025	Dec. 31, 2024
Number of options
Beginning balance (in shares)	10,984,738
Granted (in shares)	0
Exercised (in shares)	(4,202,187)
Forfeited and expired (in shares)	(6,118)
Ending balance (in shares)	6,776,433	10,984,738
Exercisable (in shares)	5,652,479
Unvested (in shares)	1,123,954
Weighted  average  exercise price  ($)
Beginning balance (in usd per share)	$ 1.67
Granted (in usd per share)	0
Exercised (in usd per share)	1.65
Forfeited and expired (in usd per share)	4.73
Ending balance (in usd per share)	1.67	$ 1.67
Exercisable (in usd per share)	1.48
Unvested (in usd per share)	$ 2.67
Weighted average remaining contractual term (years)
Balance	6 years 3 months 21 days	6 years 7 months 20 days
Exercisable	5 years 10 months 28 days
Unvested	8 years 3 months 29 days
Aggregate intrinsic value ($)
Beginning balance	$ 75,270
Ending balance	87,857	$ 75,270
Exercisable	74,408
Unvested	$ 13,449

XML

STOCK-BASED COMPENSATION - RSU Awards (Details) - RSUs	6 Months Ended
	Jun. 30, 2025 $ / shares shares
Number of RSUs
Unvested, beginning balance (in shares) | shares	8,787,022
Granted (in shares) | shares	4,773,987
Forfeited and expired (in shares) | shares	(166,418)
Vested (in shares) | shares	(2,499,947)
Unvested, ending balance (in shares) | shares	10,894,644
Weighted average Grant Date Fair Value ($)
Unvested, beginning balance (in usd per share) | $ / shares	$ 2.25
Granted (in usd per share) | $ / shares	9.28
Forfeited and expired (in usd per share) | $ / shares	4.88
Vested (in usd per share) | $ / shares	2.47
Unvested, ending balance (in usd per share) | $ / shares	$ 5.24

XML

STOCK-BASED COMPENSATION - Stock-based compensation expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	$ 6,671	$ 4,221	$ 10,664	$ 7,730
ESPP
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation			200
Cost of revenue
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	231	154	373	329
Research and development
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	2,329	1,311	3,783	2,432
General and administrative
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	3,083	2,248	4,900	4,206
Sales and marketing
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	$ 1,028	$ 508	$ 1,608	$ 763

XML

COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Operating lease cost	$ 0.5	$ 0.6	$ 1.0	$ 1.0

XML

NET LOSS PER SHARE - Computation (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Numerator:
Net loss attributable to common stockholders - basic	$ (167,329)	$ (17,778)	$ (172,750)	$ (35,090)
Net loss attributable to common stockholders - diluted	$ (167,329)	$ (17,778)	$ (172,750)	$ (35,090)
Denominator:
Weighted-average common stock outstanding, basic (in shares)	302,288,793	172,139,085	294,398,419	166,723,787
Weighted-average common stock outstanding, diluted (in shares)	302,288,793	172,139,085	294,398,419	166,723,787
Net loss per share attributable to common stockholders - basic (in usd per share)	$ (0.55)	$ (0.10)	$ (0.59)	$ (0.21)
Net loss per share attributable to common stockholders - diluted (in usd per share)	$ (0.55)	$ (0.10)	$ (0.59)	$ (0.21)

XML

NET LOSS PER SHARE - Potentially Dilutive Securities (Details) - shares	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	32,321,210	50,412,719
Warrants | Public Warrants as converted to Common Shares (Note 7)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	5,387,118	14,420,065
Warrants | Private Warrants as converted to Common Shares (Note 7)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	8,107,302	11,633,060
Warrants | D-Wave Systems Warrant Preferred Shares as converted to Common Shares (Note 7)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	1,155,713	1,155,713
Stock options issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	6,776,433	12,966,583
Unvested restricted stock unit awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	10,894,644	10,237,298

XML

SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)	6 Months Ended
	Jun. 30, 2025 segment
Segment Reporting [Abstract]
Number of operating segments	1

XML

SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Long-lived assets by geographic area (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	$ 11,419	$ 11,394
Canada
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	10,883	11,005
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	470	381
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	$ 66	$ 8

XML

SUBSEQUENT EVENTS (Details) $ / shares in Units, $ in Thousands			6 Months Ended
	Aug. 07, 2025 USD ($) $ / shares Rate shares	Aug. 01, 2025 USD ($)	Jun. 30, 2025 USD ($) shares	Jun. 30, 2024 USD ($)	Mar. 31, 2026 USD ($)	Dec. 31, 2024 USD ($) shares
Subsequent Event [Line Items]
Operating lease right-of-use assets			$ 6,915			$ 7,261
Number of warrants into which each warrant was converted (in shares) | shares			1
Common stock, issued (in shares) | shares			339,837,650			266,595,867
Proceeds from the issuance of common stock upon exercise of stock options			$ 6,860	$ 43
Subsequent Event
Subsequent Event [Line Items]
Operating lease right-of-use assets					$ 1,000
Total lease liabilities					$ 1,000
Proceeds from the issuance of common stock upon exercise of stock options	$ 15,000
Debt instrument increase decrease in basis spread on variable rate (as a percent)	0.022
Loans receivable, basis spread on variable rate (as a percent) | Rate	7.50%
Loans receivable initial basis spread on variable rate (as a percent) | Rate	9.70%
Subsequent Event | Trinity Capital Inc | Equipment Financing Agreement
Subsequent Event [Line Items]
Repayments of debt		$ 13,800
Repayments of related party debt		500
Repayments of other long-term debt		$ 11,500
Commitment fee percentage (as a percent)		1.00%
Non-utilization fee, percentage (as a percent)		0.03
Warrant to purchase, period (in years)	10 years
Warrants to purchase | shares	21,563
Warrant exercise price (in usd per share) | $ / shares	$ 16.05